Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 423 articles:
HTML format
Text format



Single Articles


    November 2018
  1. ITO K, Teng R, Schoder H, Humm JL, et al
    F-18 FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.213652. doi: 10.2967/jnumed.118.213652.
    PubMed     Text format     Abstract available


  2. YOUSSEF M, Matthews R
    Nuclear Medicine Board Review: Questions and Answers for Self-Assessment, 4th Edition.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.223172. doi: 10.2967/jnumed.118.223172.
    PubMed     Text format    


  3. VAN BERKEL A, Vriens D, Visser E, Janssen M, et al
    Metabolic subtyping of pheochromocytoma and paraganglioma by (18)F-FDG pharmacokinetics using dynamic PET/CT scanning.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.216796. doi: 10.2967/jnumed.118.216796.
    PubMed     Text format     Abstract available


  4. DMOCHOWSKA N, Tieu W, Keller M, Wardill H, et al
    Immuno-PET of innate immune markers CD11b and IL-1beta detect inflammation in murine colitis.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.219287. doi: 10.2967/jnumed.118.219287.
    PubMed     Text format     Abstract available


  5. LU Y, Sweiss N
    Role of (18)F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring: Addition to the Expert Consensus.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.221549. doi: 10.2967/jnumed.118.221549.
    PubMed     Text format    


  6. ZHUANG M, Vallez Garcia D, Kramer GM, Frings V, et al
    Variability and repeatability of quantitative uptake metrics in [(18)F]FDG PET/CT imaging of non-small cell lung cancer: impact of segmentation method, uptake interval, and reconstruction protocol.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.216028. doi: 10.2967/jnumed.118.216028.
    PubMed     Text format     Abstract available


  7. ZLATOPOLSKIY BD, Endepols H, Krapf P, Guliyev M, et al
    Discovery of (18)F-JK-PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.218495. doi: 10.2967/jnumed.118.218495.
    PubMed     Text format     Abstract available


  8. WILSON T, Xavier MA, Knight J, Verhoog S, et al
    PET imaging of PARP expression using [(18)F]olaparib.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.213223. doi: 10.2967/jnumed.118.213223.
    PubMed     Text format     Abstract available


  9. PAPP L, Rausch I, Grahovac M, Hacker M, et al
    Optimized feature extraction for radiomics analysis of (18)F-FDG-PET imaging.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217612. doi: 10.2967/jnumed.118.217612.
    PubMed     Text format     Abstract available


  10. MELLHAMMAR EM, Dahlbom M, Evans-Axelsson S, Strand SE, et al
    Preserving preclinical PET quality during intratherapeutic imaging in radionuclide therapy with Rose metal shielding reducing photon flux.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217117. doi: 10.2967/jnumed.118.217117.
    PubMed     Text format     Abstract available


  11. PERRIN M, Roch V, Claudin M, Verger A, et al
    Assessment of myocardial CZT-SPECT recording in a forward-leaning "biker-like" position.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217695. doi: 10.2967/jnumed.118.217695.
    PubMed     Text format     Abstract available


  12. FREUDENBERG LS, Hicks RJ, Beyer T
    AN INTERNATIONAL SURVEY ON CLINICAL REPORTING OF DUAL-MODALITY PET/CT IMAGING EXAMINATIONS: A STARTING POINT FOR CROSS-SPECIALTY ENGAGEMENT.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.218073. doi: 10.2967/jnumed.118.218073.
    PubMed     Text format     Abstract available


  13. LI Y, Langhorst J, Koch AK, Demircioglu A, et al
    Assessment of ileocolonic inflammation in Crohn's disease - Which surrogate marker is better? MaRIA, Clermont or PET-MR index? Initial results of a feasibility trial.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.216937. doi: 10.2967/jnumed.118.216937.
    PubMed     Text format     Abstract available


  14. MINOSHIMA S
    SNMMI Leadership Update: SNMMI Committed to Promotion of Women in Nuclear Medicine.
    J Nucl Med. 2018;59:18N.
    PubMed     Text format    


    October 2018
  15. RAUSCH I, Ruiz A, Valverde-Pascual I, Cal-Gonzalez J, et al
    Performance evaluation of the Philips Vereos PET/CT system according to the NEMA NU2-2012 standard.
    J Nucl Med. 2018 Oct 25. pii: jnumed.118.215541. doi: 10.2967/jnumed.118.215541.
    PubMed     Text format     Abstract available


  16. KURLAND BF, Peterson LM, Shields AT, Lee JH, et al
    Test-retest reproducibility of FDG-PET/CT uptake in cancer patients within a qualified and calibrated local network.
    J Nucl Med. 2018 Oct 25. pii: jnumed.118.209544. doi: 10.2967/jnumed.118.209544.
    PubMed     Text format     Abstract available


  17. LESNIAK WG, Chu C, Jablonska A, Du Y, et al
    PET imaging of intra-arterial (89)Zr bevacizumab in mice with and without osmotic opening of the blood-brain barrier: distinct advantage of intra-arterial delivery.
    J Nucl Med. 2018 Oct 12. pii: jnumed.118.218792. doi: 10.2967/jnumed.118.218792.
    PubMed     Text format     Abstract available


  18. COLLIJ L, Konijnenberg E, Reimand J, Ten Kate M, et al
    Assessing Amyloid Pathology in Cognitively Normal Subjects using [(18)F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods.
    J Nucl Med. 2018 Oct 12. pii: jnumed.118.211532. doi: 10.2967/jnumed.118.211532.
    PubMed     Text format     Abstract available


  19. ROHDE M, Nielsen AL, Pareek M, Johansen J, et al
    PET/CT versus standard imaging for prediction of survival in patients with recurrent head and neck squamous cell carcinoma.
    J Nucl Med. 2018 Oct 12. pii: jnumed.118.217976. doi: 10.2967/jnumed.118.217976.
    PubMed     Text format     Abstract available


  20. LEE H, Lazor JW, Assadsangabi R, Shah J, et al
    An imager's guide to perineural tumor spread in head and neck cancers: radiological footprints on (18)F-FDG PET with CT and MRI correlates.
    J Nucl Med. 2018 Oct 5. pii: jnumed.118.214312. doi: 10.2967/jnumed.118.214312.
    PubMed     Text format     Abstract available


  21. JACENE HA
    2018 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2018;59:7N-13N.
    PubMed     Text format    


    September 2018
  22. SCHWARZ SW, Decristoforo C, Goodbody AE, Singhal N, et al
    Harmonization of United States, European Union and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals-Is This Possible?
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.209460. doi: 10.2967/jnumed.118.209460.
    PubMed     Text format     Abstract available


  23. KOOLE M, Schmidt M, Hijzen A, Ravenstijn P, et al
    (18)F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability and occupancy of the P2X7 antagonist JNJ-54175446.
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.216747. doi: 10.2967/jnumed.118.216747.
    PubMed     Text format     Abstract available


  24. BETANCUR JA, Hu LH, Commandeur F, Sharir T, et al
    Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study.
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.213538. doi: 10.2967/jnumed.118.213538.
    PubMed     Text format     Abstract available


  25. CHAPLE IF, Lapi SE
    Production and use of first row transition metal PET radionuclides, (43,44)Sc, (52)Mn, and (45)Ti.
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.213264. doi: 10.2967/jnumed.118.213264.
    PubMed     Text format     Abstract available


  26. RAY BANEREJEE S, Kumar V, Lisok A, Plyku D, et al
    Evaluation of (111)In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.
    J Nucl Med. 2018 Sep 20. pii: jnumed.118.214403. doi: 10.2967/jnumed.118.214403.
    PubMed     Text format     Abstract available


  27. ULANER GA, Juarez J, Riedl C, Goldman D, et al
    (18)F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men.
    J Nucl Med. 2018 Sep 20. pii: jnumed.118.217836. doi: 10.2967/jnumed.118.217836.
    PubMed     Text format     Abstract available


  28. BURLEY TA, Pieve CD, Martins CD, Ciobota DM, et al
    Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.216069. doi: 10.2967/jnumed.118.216069.
    PubMed     Text format     Abstract available


  29. KWIECINSKI J, Berman DS, Lee SE, Dey D, et al
    Three-hour delayed imaging improves assessment of coronary (18)F-sodium fluoride PET.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.217885. doi: 10.2967/jnumed.118.217885.
    PubMed     Text format     Abstract available


  30. LANDAU SM
    Optimizing longitudinal beta-amyloid PET measurement: The challenges of intensity normalization.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.212662. doi: 10.2967/jnumed.118.212662.
    PubMed     Text format    


  31. PAUL S, Haskali MB, Liow JS, Zoghbi SS, et al
    Evaluation of a novel PET radioligand to image O-GlcNAcase in brain and periphery of rhesus monkey and knock-out mouse.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.213231. doi: 10.2967/jnumed.118.213231.
    PubMed     Text format     Abstract available


  32. BIEGON A, Franceschi D, Schweitzer M
    Response to Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women - Unappreciated or Otherwise.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.218834. doi: 10.2967/jnumed.118.218834.
    PubMed     Text format    


  33. WERNER RA, Bundschuh RA, Bundschuh L, Javadi MS, et al
    Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on (18)F-DCFPyL PET/CT Imaging.
    J Nucl Med. 2018 Sep 6. pii: jnumed.118.217588. doi: 10.2967/jnumed.118.217588.
    PubMed     Text format     Abstract available


  34. YIN Y, Werner RA, Higuchi T, Lapa C, et al
    Follow-Up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.
    J Nucl Med. 2018 Sep 6. pii: jnumed.118.217653. doi: 10.2967/jnumed.118.217653.
    PubMed     Text format     Abstract available


  35. MINOSHIMA S
    SNMMI Leadership Update: Training Future Nuclear Medicine Physicians.
    J Nucl Med. 2018;59:17N-18N.
    PubMed     Text format    


    August 2018
  36. TORRADO-CARVAJAL A, Vera-Olmos J, Izquierdo-Garcia D, Catalano OA, et al
    Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction.
    J Nucl Med. 2018 Aug 30. pii: jnumed.118.209288. doi: 10.2967/jnumed.118.209288.
    PubMed     Text format     Abstract available


  37. SPUHLER KD, Gardus J 3rd, Gao Y, DeLorenzo C, et al
    Synthesis of patient-specific transmission image for PET attenuation correction for PET/MR imaging of the brain using a convolutional neural network'.
    J Nucl Med. 2018 Aug 30. pii: jnumed.118.214320. doi: 10.2967/jnumed.118.214320.
    PubMed     Text format     Abstract available


  38. SIEGEL JA, Greenspan BS, Silberstein EB, Sacks B, et al
    Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women - Unappreciated or Otherwise.
    J Nucl Med. 2018 Aug 30. pii: jnumed.118.218842. doi: 10.2967/jnumed.118.218842.
    PubMed     Text format    


  39. MEIER JG, Wu CC, Betancourt Cuellar SL, Truong MT, et al
    Evaluation of a novel elastic respiratory motion correction algorithm on quantification and image quality in abdomino-thoracic PET/CT.
    J Nucl Med. 2018 Aug 16. pii: jnumed.118.213884. doi: 10.2967/jnumed.118.213884.
    PubMed     Text format     Abstract available


  40. GOULD KL, Johnson NP, Roby A, Nguyen TT, et al
    Regional Artery Specific Thresholds Of Quantitative Myocardial Perfusion By PET Associated With Reduced MI and Death After Revascularization In Stable CAD.
    J Nucl Med. 2018 Aug 16. pii: jnumed.118.211953. doi: 10.2967/jnumed.118.211953.
    PubMed     Text format     Abstract available


  41. EVANGELISTA L, Zattoni F
    THE WAR IS OPENED: PSMA VS. (64)CuCL2 VS. CHOLINE PET/CT.
    J Nucl Med. 2018 Aug 16. pii: jnumed.118.218289. doi: 10.2967/jnumed.118.218289.
    PubMed     Text format    


  42. KUWABARA H, Comley RA, Borroni E, Honer M, et al
    Evaluation of (18)F-RO-948 ((18)F-RO6958948) for quantitative assessment of tau accumulation in the human brain with positron emission tomography.
    J Nucl Med. 2018 Aug 10. pii: jnumed.118.214437. doi: 10.2967/jnumed.118.214437.
    PubMed     Text format     Abstract available


  43. TINKLE C, Duncan E, Doubrovin M, Han Y, et al
    Evaluation of (11)C-methionine PET and anatomic MRI associations in diffuse intrinsic pontine glioma.
    J Nucl Med. 2018 Aug 2. pii: jnumed.118.212514. doi: 10.2967/jnumed.118.212514.
    PubMed     Text format     Abstract available


  44. VOUTSINAS N, Lekperic S, Barazani S, Titano JJ, et al
    Interventional Oncology: Treatment of primary liver tumors and liver metastases. Part I: Nuclear medicine techniques (all about spheres).
    J Nucl Med. 2018 Aug 2. pii: jnumed.116.186346. doi: 10.2967/jnumed.116.186346.
    PubMed     Text format     Abstract available


  45. GIESEL F, Kratochwil C, Lindner T, Marschalek M, et al
    FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers.
    J Nucl Med. 2018 Aug 2. pii: jnumed.118.215913. doi: 10.2967/jnumed.118.215913.
    PubMed     Text format     Abstract available


  46. PAPPAS V
    SNMMI Leadership Update: The SNMMI 2018 Annual Meeting-New Energy and Excitement in Nuclear Medicine.
    J Nucl Med. 2018;59:17N.
    PubMed     Text format    


    July 2018
  47. GIESEL FL, Knorr K, Spohn F, Will L, et al
    Detection efficacy of [(18)F]PSMA-1007 PET/CT in 251 Patients with biochemical recurrence after radical prostatectomy.
    J Nucl Med. 2018 Jul 24. pii: jnumed.118.212233. doi: 10.2967/jnumed.118.212233.
    PubMed     Text format     Abstract available


  48. AZAD G, Siddique MM, Taylor B, Green A, et al
    Does measurement of (18)F-fluoride metabolic flux improve response assessment of breast cancer bone metastases compared with standardised uptake values in (18)F-fluoride PET/CT?
    J Nucl Med. 2018 Jul 24. pii: jnumed.118.208710. doi: 10.2967/jnumed.118.208710.
    PubMed     Text format     Abstract available


  49. PICHLER V, Berroteran-Infante N, Philippe C, Vraka C, et al
    An overview on PET radiochemistry: part 1 - covalent labels - (18)F, (11)C, and (13)N.
    J Nucl Med. 2018 Jul 24. pii: jnumed.117.190793. doi: 10.2967/jnumed.117.190793.
    PubMed     Text format     Abstract available


  50. COLLARINO A, Garganese G, Fragomeni SM, Pereira Arias-Bouda LM, et al
    Radiomics in vulvar cancer: first clinical experience using (18)F-FDG PET/CT images.
    J Nucl Med. 2018 Jul 20. pii: jnumed.118.215889. doi: 10.2967/jnumed.118.215889.
    PubMed     Text format     Abstract available


  51. TURGEON GA, Iravani A, Akhurst T, Beaulieu A, et al
    What FDG-PET response-assessment method best predicts survival after curative-intent chemoradiation in non-small cell lung cancer (NSCLC): EORTC, PERCIST, Peter Mac or Deauville criteria?
    J Nucl Med. 2018 Jul 20. pii: jnumed.118.214148. doi: 10.2967/jnumed.118.214148.
    PubMed     Text format     Abstract available


  52. HAN S, Suh CH, Woo S, Kim YJ, et al
    Performance of (68)Ga-DOTA-Conjugated Somatostatin Receptor Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Meta-Analysis.
    J Nucl Med. 2018 Jul 20. pii: jnumed.118.211706. doi: 10.2967/jnumed.118.211706.
    PubMed     Text format     Abstract available


  53. KESLER M, Levine C, Hershkovitz D, Mishani E, et al
    (68)Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study.
    J Nucl Med. 2018 Jul 12. pii: jnumed.118.214833. doi: 10.2967/jnumed.118.214833.
    PubMed     Text format     Abstract available


  54. AL-ZAGHAL A, Mehdizadeh Seraj S, Werner TJ, Gerke O, et al
    Assessment of Physiological Intracranial Calcification in Healthy Adults Using (18)F-NaF PET/CT.
    J Nucl Med. 2018 Jul 12. pii: jnumed.118.213678. doi: 10.2967/jnumed.118.213678.
    PubMed     Text format     Abstract available


  55. SCHMIDT-HEGEMANN NS, Stief C, Kim TH, Eze C, et al
    Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.
    J Nucl Med. 2018 Jul 12. pii: jnumed.118.212563. doi: 10.2967/jnumed.118.212563.
    PubMed     Text format     Abstract available


  56. DE BRUYCKER S, Vangestel C, Van den Wyngaert T, Pauwels P, et al
    (18)F-HX4 Hypoxia PET Holds Promise as a Prognostic and Predictive Imaging Biomarker in a Lung Cancer Xenograft Model Treated with Metformin and Radiotherapy.
    J Nucl Med. 2018 Jul 6. pii: jnumed.118.212225. doi: 10.2967/jnumed.118.212225.
    PubMed     Text format     Abstract available


  57. TRAN-GIA J, Lassmann M
    Characterization of Noise and Resolution for Quantitative (177)Lu SPECT/CT with xSPECT Quant.
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.211094. doi: 10.2967/jnumed.118.211094.
    PubMed     Text format     Abstract available


  58. KOERBER SA, Will L, Kratochwil C, Haefner MF, et al
    (68)Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients.
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.211086. doi: 10.2967/jnumed.118.211086.
    PubMed     Text format     Abstract available


  59. BARTNICKA JJ, Blower P
    Insights into trace metal metabolism in health and disease from PET: "PET metallomics".
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.212803. doi: 10.2967/jnumed.118.212803.
    PubMed     Text format     Abstract available


  60. CHANEY A, Cropper HC, Johnson EM, Lechtenberg KJ, et al
    (11)C-DPA-713 versus (18)F-GE-180: A preclinical comparison of TSPO-PET tracers to visualize acute and chronic neuroinflammation in a mouse model of ischemic stroke.
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.209155. doi: 10.2967/jnumed.118.209155.
    PubMed     Text format     Abstract available


    June 2018
  61. IMANLI H HASAN.IMAN, Ume KL, Jeudy J, Bob-Manuel T, et al
    VT Substrate Characteristics: Insights from Multi-modality Structural and Functional Imaging of the VT Substrate Using CMR Scar, (123)I-mIBG-SPECT Innervation and Bipolar Voltage.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.211698. doi: 10.2967/jnumed.118.211698.
    PubMed     Text format     Abstract available


  62. HEISS WD
    The additional value of PET in the assessment of cerebral small vessel disease.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.214270. doi: 10.2967/jnumed.118.214270.
    PubMed     Text format     Abstract available


  63. KIM MJ, Shrestha SS, Cortes M, Singh P, et al
    Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.211144. doi: 10.2967/jnumed.118.211144.
    PubMed     Text format     Abstract available


  64. KIM C, Lee JS, Han Y, Chae SY, et al
    Glycoprotein IIb/IIIa receptor imaging with (18)F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.212084. doi: 10.2967/jnumed.118.212084.
    PubMed     Text format     Abstract available


  65. WOFF E, Hendlisz A, Ameye L, Garcia C, et al
    Metabolic Active Tumor Volume and Total Lesion Glycolysis by (18)F-FDG PET/CT Validated as Prognostic Imaging Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.210161. doi: 10.2967/jnumed.118.210161.
    PubMed     Text format     Abstract available


  66. DIVGI CR
    Radiopharmaceutical therapy in the new millenium.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.214122. doi: 10.2967/jnumed.118.214122.
    PubMed     Text format    


  67. CHEN KT, Salcedo S, Gong K, Chonde DB, et al
    An Efficient Approach to Perform MR-assisted PET Data Optimization in Simultaneous PET/MR Neuroimaging Studies.
    J Nucl Med. 2018 Jun 22. pii: jnumed.117.207142. doi: 10.2967/jnumed.117.207142.
    PubMed     Text format     Abstract available


  68. GU Z, Taschereau R, Vu N, Prout DL, et al
    Performance evaluation of G8, a high sensitivity benchtop preclinical PET/CT tomograph.
    J Nucl Med. 2018 Jun 14. pii: jnumed.118.208827. doi: 10.2967/jnumed.118.208827.
    PubMed     Text format     Abstract available


  69. LODGE MA, Leal JP, Rahmim A, Sunderland JJ, et al
    Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle.
    J Nucl Med. 2018 Jun 14. pii: jnumed.118.209593. doi: 10.2967/jnumed.118.209593.
    PubMed     Text format     Abstract available


  70. LILJA J, Leuzy A, Chiotis K, Savitcheva I, et al
    Spatial normalization of [(18)F]flutemetamol PET images utilizing an adaptive principal components template.
    J Nucl Med. 2018 Jun 14. pii: jnumed.118.207811. doi: 10.2967/jnumed.118.207811.
    PubMed     Text format     Abstract available


  71. LOHITH TG, Bennacef I, Vandenberghe R, Vandenbulcke M, et al
    First-in-human brain imaging of Alzheimer dementia patients and elderly controls with (18)F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology.
    J Nucl Med. 2018 Jun 7. pii: jnumed.118.208215. doi: 10.2967/jnumed.118.208215.
    PubMed     Text format     Abstract available


  72. SAH BR, Ghafoor S, Burger IA, Ter Voert EEGW, et al
    Feasibility of (18)F-FDG Dose Reductions in Breast Cancer PET/MRI.
    J Nucl Med. 2018 Jun 7. pii: jnumed.118.209007. doi: 10.2967/jnumed.118.209007.
    PubMed     Text format     Abstract available


    May 2018
  73. MEIER SR, Syvanen S, Hultqvist G, Fang XT, et al
    Antibody-based in vivo PET imaging detects amyloid-beta reduction in Alzheimer transgenic mice after BACE-1 inhibition.
    J Nucl Med. 2018 May 31. pii: jnumed.118.213140. doi: 10.2967/jnumed.118.213140.
    PubMed     Text format     Abstract available


  74. MA X, Shengjun W, Wang S, Liu D, et al
    Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin Targeted PET Probe (18)F-P3BZA in Patients.
    J Nucl Med. 2018 May 31. pii: jnumed.118.209643. doi: 10.2967/jnumed.118.209643.
    PubMed     Text format     Abstract available


  75. BERTOGLIO D, Kosten L, Verhaeghe J, Thomae D, et al
    Longitudinal characterization of mGluR5 using (11)C-ABP688 PET imaging in the Q175 mouse model of Huntington's disease.
    J Nucl Med. 2018 May 24. pii: jnumed.118.210658. doi: 10.2967/jnumed.118.210658.
    PubMed     Text format     Abstract available


  76. HEINZMANN K, Nguyen QD, Honess DJ, Smith DM, et al
    Depicting changes in tumor biology in response to cetuximab mono- or combination therapy by apoptosis and proliferation imaging using (18)F-ICMT-11 and 3'-Deoxy-3'-[(18)F]Fluorothymidine ((18)F-FLT) PET.
    J Nucl Med. 2018 May 24. pii: jnumed.118.209304. doi: 10.2967/jnumed.118.209304.
    PubMed     Text format     Abstract available


  77. THALGOTT M, Duwel C, Rauscher I, Heck MM, et al
    One-stop shop whole-body (68)Ga-PSMA-11 PET/MRI compared to clinical Nomograms for preoperative T- and N-Staging of High-Risk Prostate Cancer.
    J Nucl Med. 2018 May 24. pii: jnumed.117.207696. doi: 10.2967/jnumed.117.207696.
    PubMed     Text format     Abstract available


  78. WOO SK, Jang SJ, Seo MJ, Park JH, et al
    Development of (64)Cu-NOTA-Trastuzumab for HER2 targeting: radiopharmaceutical with improved pharmacokinetics for human study.
    J Nucl Med. 2018 May 18. pii: jnumed.118.210294. doi: 10.2967/jnumed.118.210294.
    PubMed     Text format     Abstract available


  79. BETTHAUSER TJ, Cody KA, Zammit MD, Murali D, et al
    In vivo characterization and quantification of neurofibrillary tau PET radioligand [(18)F]MK-6240 in humans from Alzheimer's disease dementia to young controls.
    J Nucl Med. 2018 May 18. pii: jnumed.118.209650. doi: 10.2967/jnumed.118.209650.
    PubMed     Text format     Abstract available


  80. HAN Z, Xiao Y, Wang K, Yan J, et al
    Development of a Novel SPECT Tracer to Image c-Met Expression in Non-Small Cell Lung Cancer in a Human Tumor Xenograft.
    J Nucl Med. 2018 May 18. pii: jnumed.117.206730. doi: 10.2967/jnumed.117.206730.
    PubMed     Text format     Abstract available


  81. CHIAO P, Bedell BJ, Avants B, Zijdenbos AP, et al
    Impact of Reference/Target Region Selection on Amyloid PET Standard Uptake Value Ratios in the Phase 1b PRIME Study of Aducanumab.
    J Nucl Med. 2018 May 18. pii: jnumed.118.209130. doi: 10.2967/jnumed.118.209130.
    PubMed     Text format     Abstract available


  82. BRANDT M, Cardinale J, Aulsebrook M, Gasser G, et al
    AN OVERVIEW ON PET RADIOCHEMISTRY: PART 2 - RADIOMETALS.
    J Nucl Med. 2018 May 10. pii: jnumed.117.190801. doi: 10.2967/jnumed.117.190801.
    PubMed     Text format     Abstract available


  83. AUVITY S, Caille F, Marie S, Wimberley C, et al
    P-glycoprotein (ABCB1) inhibits the influx and increases the efflux of (11)C-metoclopramide across the blood-brain barrier: a PET study on non-human primates.
    J Nucl Med. 2018 May 10. pii: jnumed.118.210104. doi: 10.2967/jnumed.118.210104.
    PubMed     Text format     Abstract available


  84. PETERSON LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, et al
    Prospective study of serial (18)F-FDG PET and (18)F-fluoride ((18)F-NaF) PET to predict time to skeletal related events, time-to-progression, and survival in patients with bone-dominant metastatic breast cancer.
    J Nucl Med. 2018 May 10. pii: jnumed.118.211102. doi: 10.2967/jnumed.118.211102.
    PubMed     Text format     Abstract available


  85. WONG DF, Comley R, Kuwabara H, Rosenberg PB, et al
    First in-human PET study of 3 novel tau radiopharmaceuticals: [(11)C]RO6924963, [(11)C]RO6931643, and [(18)F]RO6958948.
    J Nucl Med. 2018 May 4. pii: jnumed.118.209916. doi: 10.2967/jnumed.118.209916.
    PubMed     Text format     Abstract available


  86. DOUGHTON JA, Hofman MS, Eu P, Hicks RJ, et al
    A first-in-man study of (68)Ga-nanocolloid PET-CT sentinel lymph node imaging in prostate cancer demonstrates aberrant lymphatic drainage pathways.
    J Nucl Med. 2018 May 4. pii: jnumed.118.209171. doi: 10.2967/jnumed.118.209171.
    PubMed     Text format     Abstract available


  87. ELSCHOT M, Selnaes KM, Johansen H, Kruger-Stokke B, et al
    The Effect of Including Bone in DIXON-based Attenuation Correction for (18)F-fluciclovine PET/MRI of Prostate Cancer.
    J Nucl Med. 2018 May 4. pii: jnumed.118.208868. doi: 10.2967/jnumed.118.208868.
    PubMed     Text format     Abstract available


  88. BURGGRAAFF CN, Cornelisse AC, Hoekstra OS, Lugtenburg PJ, et al
    Interobserver agreement of interim and end-of-treatment (18)F-FDG PET/CT in diffuse large B-cell lymphoma (DLBCL): impact on clinical practice and trials.
    J Nucl Med. 2018 May 4. pii: jnumed.118.210807. doi: 10.2967/jnumed.118.210807.
    PubMed     Text format     Abstract available


  89. WEIST MR, Starr R, Aguilar B, Chea J, et al
    Positron emission tomography of adoptively transferred chimeric antigen receptor T cells with Zirconium-89 oxine.
    J Nucl Med. 2018 May 4. pii: jnumed.117.206714. doi: 10.2967/jnumed.117.206714.
    PubMed     Text format     Abstract available



  90. Reclassifying Diagnostic Radiopharmaceuticals.
    J Nucl Med. 2018;59:8N.
    PubMed     Text format    


    April 2018
  91. WU J, Wang S, Zhang X, Teng Z, et al
    (18)F-Alfatide II PET/CT for Identification of Breast Cancer: A Preliminary Clinical Study.
    J Nucl Med. 2018 Apr 26. pii: jnumed.118.208637. doi: 10.2967/jnumed.118.208637.
    PubMed     Text format     Abstract available


  92. HATHI D, DeLassus E, Achilefu S, McConathy J, et al
    Imaging melphalan therapy response in preclinical extramedullary myeloma with (18)F-FDOPA and (18)F-FDG PET.
    J Nucl Med. 2018 Apr 26. pii: jnumed.118.208744. doi: 10.2967/jnumed.118.208744.
    PubMed     Text format     Abstract available


  93. SALAS JR, Chen BY, Wong A, Cheng D, et al
    (18)F-FAC PET selectively images hepatic infiltrating CD4 and CD8 T cells in a mouse model of autoimmune hepatitis.
    J Nucl Med. 2018 Apr 26. pii: jnumed.118.210328. doi: 10.2967/jnumed.118.210328.
    PubMed     Text format     Abstract available


  94. FOSS CA, Plyku D, Ordonez AA, Sanchez-Bautista J, et al
    Biodistribution and Radiation Dosimetry of (124)I-iodo-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation.
    J Nucl Med. 2018 Apr 26. pii: jnumed.117.207431. doi: 10.2967/jnumed.117.207431.
    PubMed     Text format     Abstract available


  95. MCHUGH C, Thipparthi MR, Lawhorn-Crews JM, Polin L, et al
    Utilizing radiolabeled 3'-deoxy-3'-[(18)F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.
    J Nucl Med. 2018 Apr 19. pii: jnumed.117.207258. doi: 10.2967/jnumed.117.207258.
    PubMed     Text format     Abstract available


  96. GROHEUX D
    Now is the time to use FDG-PET/CT to optimize neoadjuvant treatment in triple negative breast cancer!
    J Nucl Med. 2018 Apr 19. pii: jnumed.118.210922. doi: 10.2967/jnumed.118.210922.
    PubMed     Text format    


  97. LOWE VJ, Lundt ES, Senjem ML, Schwarz CG, et al
    White matter reference region in PET studies of (11)C-Pittsburgh Compound B uptake: effects of age and amyloid-beta deposition.
    J Nucl Med. 2018 Apr 19. pii: jnumed.117.204271. doi: 10.2967/jnumed.117.204271.
    PubMed     Text format     Abstract available


  98. GEORGI TW, Kluge R, Kurch L, Chavdarova L, et al
    FDG-PET response of skeletal (bone marrow and bone) involvement after induction chemotherapy in pediatric Hodgkin lymphoma - Are specific response criteria required?
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.205633. doi: 10.2967/jnumed.117.205633.
    PubMed     Text format     Abstract available


  99. CALAIS J, Kishan AU, Cao M, Fendler WP, et al
    Potential impact of (68)Ga-PSMA-11 PET/CT on prostate cancer definitive radiation therapy planning.
    J Nucl Med. 2018 Apr 13. pii: jnumed.118.209387. doi: 10.2967/jnumed.118.209387.
    PubMed     Text format     Abstract available


  100. WARDAK M, Gowrishankar G, Gambhir SS
    Reply: 6"-18F-Fluoromaltotriose PET Evaluation in Escherichia-Coli-Induced Myositis: is there Uptake Saturation in Control?
    J Nucl Med. 2018 Apr 13. pii: jnumed.118.208736. doi: 10.2967/jnumed.118.208736.
    PubMed     Text format    


  101. REILHAC A, Merida I, Irace Z, Stephenson M, et al
    Development and validation of a rebinner with rigid motion correction for the Siemens PET-MR scanner: Application to a large cohort of [(11)C]-PIB scans.
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.206375. doi: 10.2967/jnumed.117.206375.
    PubMed     Text format     Abstract available


  102. TANG L, Peng C, Tang B, Li Z, et al
    Radioiodinated Small Molecule Tyrosine Kinase Inhibitor for HER2 Selective SPECT Imaging.
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.205088. doi: 10.2967/jnumed.117.205088.
    PubMed     Text format     Abstract available


  103. PIJL JP, Glaudemans AWJM, Slart RHJA, Kwee TC, et al
    FDG-PET/CT in autosomal dominant polycystic kidney disease patients with suspected cyst infection.
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.199448. doi: 10.2967/jnumed.117.199448.
    PubMed     Text format     Abstract available


  104. RADHAKRISHNAN R, Nabulsi N, Gaiser E, Gallezot JD, et al
    Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with (11)C-GSK215083 PET.
    J Nucl Med. 2018 Apr 6. pii: jnumed.117.206516. doi: 10.2967/jnumed.117.206516.
    PubMed     Text format     Abstract available


  105. BOELLAARD R, Kobe C, Zijlstra JM, Mikhaeel G, et al
    Does PET reconstruction method affect Deauville scoring in lymphoma patients?
    J Nucl Med. 2018 Apr 6. pii: jnumed.118.211607. doi: 10.2967/jnumed.118.211607.
    PubMed     Text format    



  106. Nuclear Medicine Procedure Performance and Cataracts.
    J Nucl Med. 2018;59:10N.
    PubMed     Text format    


    March 2018
  107. HARMON SA STEPHANIE., Bergvall E, Mena E, Shih JH, et al
    A Prospective Comparison of (18)F-Sodium Fluoride PET/CT and PSMA-targeted (18)F-DCFBC PET/CT in Metastatic Prostate Cancer.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.207373. doi: 10.2967/jnumed.117.207373.
    PubMed     Text format     Abstract available


  108. LUCKERATH K, Stuparu AD, Wei L, Kim W, et al
    Detection threshold and reproducibility of (68)Ga-PSMA11 PET/CT in a mouse model of prostate cancer.
    J Nucl Med. 2018 Mar 30. pii: jnumed.118.207704. doi: 10.2967/jnumed.118.207704.
    PubMed     Text format     Abstract available


  109. SCHWARZ SW, Clarke BN
    Invited Perspective on JNM manuscript titled, "How Should FDA Review Diagnostic Radiopharmaceuticals?" by Carol Marcus.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.204446. doi: 10.2967/jnumed.117.204446.
    PubMed     Text format    


  110. VAN DEN WYNGAERT T, Palli SR, Imhoff RJ, Hirschmann MT, et al
    Cost-Effectiveness of Bone SPECT/CT in Painful Total Knee Arthroplasty.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.205567. doi: 10.2967/jnumed.117.205567.
    PubMed     Text format     Abstract available


  111. WERNER RA, Solnes L, Javadi M, Weich A, et al
    SSTR-RADS Version 1.0 as a Reporting System for SSTR-PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework.
    J Nucl Med. 2018 Mar 23. pii: jnumed.117.206631. doi: 10.2967/jnumed.117.206631.
    PubMed     Text format     Abstract available


  112. MONTEMAGNO C, Bacot S, Ahmadi M, Kerfelec B, et al
    Preclinical evaluation of novel mesothelin-specific ligands for SPECT imaging of Triple Negative Breast Cancer.
    J Nucl Med. 2018 Mar 23. pii: jnumed.117.203489. doi: 10.2967/jnumed.117.203489.
    PubMed     Text format     Abstract available


  113. MILES KA, Voo SA, Groves AM
    ADDITIONAL CLINICAL VALUE FOR PET/MRI IN ONCOLOGY: MOVING BEYOND SIMPLE DIAGNOSIS.
    J Nucl Med. 2018 Mar 15. pii: jnumed.117.203612. doi: 10.2967/jnumed.117.203612.
    PubMed     Text format     Abstract available


  114. BIERSACK HJ
    Nuclear Medicine Training: Two different pathways?
    J Nucl Med. 2018 Mar 15. pii: jnumed.118.210401. doi: 10.2967/jnumed.118.210401.
    PubMed     Text format    


  115. PARENT EE, Schuster DM
    Update on (18)F-fluciclovine PET for prostate cancer imaging.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.204032. doi: 10.2967/jnumed.117.204032.
    PubMed     Text format     Abstract available


  116. MANBER R, Thielemans K, Hutton BF, Wan S, et al
    Clinical Impact of Respiratory Motion Correction in Simultaneous PET/MR with a Joint PET/MR Predictive Motion Model.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.191460. doi: 10.2967/jnumed.117.191460.
    PubMed     Text format     Abstract available


  117. SSALI T, Anazodo UC, Thiessen JD, Prato FS, et al
    A Non-invasive Method for Quantifying Cerebral Blood Flow by Hybrid PET/MR.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.203414. doi: 10.2967/jnumed.117.203414.
    PubMed     Text format     Abstract available


  118. TYACKE RJ, Myers JFM, Venkataraman A, Mick I, et al
    Evaluation of (11)C-BU99008, a positron emission tomography ligand for the Imidazoline2 binding site in human brain.
    J Nucl Med. 2018 Mar 9. pii: jnumed.118.208009. doi: 10.2967/jnumed.118.208009.
    PubMed     Text format     Abstract available


  119. ZULLO L, Buschiazzo A, Massollo M, Riondato M, et al
    (18)F-FDG micro-PET imaging for research investigations in the Octopus vulgaris: applications and future directions in invertebrate neuroscience and tissue regeneration.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.205393. doi: 10.2967/jnumed.117.205393.
    PubMed     Text format     Abstract available



  120. Thomas Named Editor of the Journal of Nuclear Medicine Technology.
    J Nucl Med. 2018;59:11N.
    PubMed     Text format    


  121. HICKS RJ
    The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement.
    J Nucl Med. 2018;59:418-420.
    PubMed     Text format    


  122. CZERNIN J
    The National Oncologic PET Registry (NOPR): A Monumental Effort by a Few Leaders.
    J Nucl Med. 2018;59:379.
    PubMed     Text format    


  123. SALAS JR, Chen BY, Wong A, Duarte S, et al
    Non-invasive imaging of drug-induced liver injury with (18)F-DFA PET.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.206961. doi: 10.2967/jnumed.117.206961.
    PubMed     Text format     Abstract available


  124. SPANU A, Nuvoli S, Gelo I, Mele L, et al
    The role of diagnostic (131)I-SPECT/TC in patients with papillary thyroid microcarcinoma in long-term follow-up.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.204636. doi: 10.2967/jnumed.117.204636.
    PubMed     Text format     Abstract available


  125. DE LAAT B, Weerasekera A, Leurquin-Sterk G, Bormans GM, et al
    Glutamatergic biomarkers for cocaine addiction: A longitudinal study in self-administering rats using MRS and mGluR5 PET.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.202614. doi: 10.2967/jnumed.117.202614.
    PubMed     Text format     Abstract available


  126. COUGHLIN JM, Slania S, Du Y, Rosenthal HB, et al
    (18)F-XTRA PET for enhanced imaging of the extrathalamic alpha4beta2 nicotinic acetylcholine receptor.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.205492. doi: 10.2967/jnumed.117.205492.
    PubMed     Text format     Abstract available


  127. CALAIS J, Fendler WP, Herrmann K, Eiber M, et al
    Reply: Comparison of (68)Ga-PSMA-11 and (18)F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective trial is on its way.
    J Nucl Med. 2018 Mar 1. pii: jnumed.118.209965. doi: 10.2967/jnumed.118.209965.
    PubMed     Text format    


  128. REZAEI A, Deroose CM, Vahle T, Boada F, et al
    Joint reconstruction of activity and attenuation in Time-of-Flight PET: A Quantitative Analysis.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.204156. doi: 10.2967/jnumed.117.204156.
    PubMed     Text format     Abstract available


    February 2018
  129. NAPIECZYNSKA H, Kolb A, Katiyar P, Tonietto M, et al
    Impact of the AIF Recording Method on Kinetic Parameters in Small Animal PET.
    J Nucl Med. 2018 Feb 23. pii: jnumed.117.204164. doi: 10.2967/jnumed.117.204164.
    PubMed     Text format     Abstract available


  130. WU J, Gallezot JD, Lu Y, Ye Q, et al
    Simplified Quantification and Acquisition Protocol of (123)I-mIBG Dynamic SPECT.
    J Nucl Med. 2018 Feb 23. pii: jnumed.117.202143. doi: 10.2967/jnumed.117.202143.
    PubMed     Text format     Abstract available


  131. DENES B, Gardiner P
    Comparison of (68)Ga-PSMA-11 PET/CT and (18)F-Fluciclovone PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive.
    J Nucl Med. 2018 Feb 23. pii: jnumed.118.209817. doi: 10.2967/jnumed.118.209817.
    PubMed     Text format    


  132. LAFFON E, Marthan R
    6"-(18)F-Fluoromaltotriose PET Evaluation in Escherichia-Coli-Induced Myositis: is there Uptake Saturation in Control?
    J Nucl Med. 2018 Feb 15. pii: jnumed.118.208645. doi: 10.2967/jnumed.118.208645.
    PubMed     Text format    


  133. LINDSTROM E, Sundin A, Trampal C, Lindsjo L, et al
    Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for (18)F-FDG whole-body examinations.
    J Nucl Med. 2018 Feb 15. pii: jnumed.117.200790. doi: 10.2967/jnumed.117.200790.
    PubMed     Text format     Abstract available


  134. LU Y, Fontaine K, Mulnix T, Onofrey JA, et al
    Respiratory Motion Compensation for PET/CT with Motion Information Derived from Matched Attenuation Corrected Gated PET Data.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.203000. doi: 10.2967/jnumed.117.203000.
    PubMed     Text format     Abstract available


  135. DE LEON MJ, Li Y, Rusinek H
    Reply: Cerebrospinal Fluid, Hyposmia and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.207068. doi: 10.2967/jnumed.117.207068.
    PubMed     Text format    


  136. CRANDALL J, O JH, Gajwani P, Leal JP, et al
    Measurement of Brown Adipose Tissue Activity Using Microwave Radiometry (MRAD) and FDG PET/CT.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.204339. doi: 10.2967/jnumed.117.204339.
    PubMed     Text format     Abstract available


  137. HUMBERT O, Lasserre M, Bertaut A, Fumoleau P, et al
    Pattern of breast cancer blood flow and metabolism, assessed using dual-acquisition (18)FDG PET: correlation with tumor phenotypic features and pathological response to neoadjuvant chemotherapy.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.203075. doi: 10.2967/jnumed.117.203075.
    PubMed     Text format     Abstract available


  138. BERG E, Zhang X, Bec J, Judenhofer MS, et al
    Development and evaluation of mini-EXPLORER: a long axial field-of-view PET scanner for non-human primate imaging.
    J Nucl Med. 2018 Feb 1. pii: jnumed.117.200519. doi: 10.2967/jnumed.117.200519.
    PubMed     Text format     Abstract available


  139. CHANTEPIE S, Hovhannisyan N, Guillouet S, Pelage JP, et al
    (18)F-Fludarabine-PET for lymphoma imaging: first-in-man study in DLBCL and CLL patients.
    J Nucl Med. 2018 Feb 1. pii: jnumed.117.206920. doi: 10.2967/jnumed.117.206920.
    PubMed     Text format     Abstract available


  140. GIESEL F, Will L, Kesch C, Freitag M, et al
    Biochemical recurrence of prostate cancer: initial results with (18)F-PSMA-1007 PET/CT.
    J Nucl Med. 2018 Feb 1. pii: jnumed.117.196329. doi: 10.2967/jnumed.117.196329.
    PubMed     Text format     Abstract available


    January 2018
  141. CZERNIN J
    The National Oncology PET Registry (NOPR): A monumental effort by a few leaders.
    J Nucl Med. 2018 Jan 25. pii: jnumed.118.207860. doi: 10.2967/jnumed.118.207860.
    PubMed     Text format    


  142. XIE T, Zanotti-Fregonara P, Edet-Sanson A, Zaidi H, et al
    Patient-specific computational model and dosimetry calculations for a patient pregnant with twins undergoing a PET/CT examination.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.205286. doi: 10.2967/jnumed.117.205286.
    PubMed     Text format     Abstract available


  143. RISCHPLER C, Beck TI, Okamoto S, Schlitter AM, et al
    (68)Ga-PSMA-HBED-CC uptake in cervical, coeliac and sacral ganglia as an important pitfall in prostate cancer PET imaging.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.204677. doi: 10.2967/jnumed.117.204677.
    PubMed     Text format     Abstract available


  144. DITTMANN HJMH, Kopp D, Kupferschlaeger J, Feil D, et al
    A prospective study of quantitative SPECT/CT for evaluation of hepatopulmonary shunt fraction prior to SIRT of liver tumors.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.205203. doi: 10.2967/jnumed.117.205203.
    PubMed     Text format     Abstract available


  145. BINI J, Naganawa M, Nabulsi NB, Huang YH, et al
    Evaluation of PET Brain Radioligands for Imaging Pancreatic beta-Cell Mass: Potential Utility of (11)C-PHNO.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.197285. doi: 10.2967/jnumed.117.197285.
    PubMed     Text format     Abstract available


  146. FUIN N DR., Catalano OA, Scipioni M, Canjels LPW, et al
    Concurrent Respiratory Motion Correction of Abdominal PET and DCE-MRI using a Compressed Sensing Approach.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.203943. doi: 10.2967/jnumed.117.203943.
    PubMed     Text format     Abstract available


  147. AARNTZEN EHJG, Heijmen L, Oyen WJG
    [(18)F]FDG PET/CT in local ablative therapies: a systematic review.
    J Nucl Med. 2018 Jan 18. pii: jnumed.117.198184. doi: 10.2967/jnumed.117.198184.
    PubMed     Text format     Abstract available


  148. MAYER AT, Gambhir SS
    Response: Optimizing Strategies for Immune Checkpoint Imaging with Immuno-PET in Preclinical Study.
    J Nucl Med. 2018 Jan 18. pii: jnumed.117.205153. doi: 10.2967/jnumed.117.205153.
    PubMed     Text format    


  149. OTTOY J, De Picker L, Verhaeghe J, Deleye S, et al
    [(18)F]PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test - Retest Reproducibility and Quantification of Neuroinflammation.
    J Nucl Med. 2018 Jan 11. pii: jnumed.117.203315. doi: 10.2967/jnumed.117.203315.
    PubMed     Text format     Abstract available


  150. KUMARIA A
    Cerebrospinal Fluid, Hyposmia and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis.
    J Nucl Med. 2018 Jan 11. pii: jnumed.117.206888. doi: 10.2967/jnumed.117.206888.
    PubMed     Text format    


  151. BAILEY DL, Hofman MS, Forwood NJ, O'Keefe GJ, et al
    ACCURACY OF DOSE CALIBRATORS FOR GALLIUM-68 PET IMAGING: UNEXPECTED FINDINGS IN A MULTI-CENTRE CLINICAL PRE-TRIAL ASSESSMENT.
    J Nucl Med. 2018 Jan 11. pii: jnumed.117.202861. doi: 10.2967/jnumed.117.202861.
    PubMed     Text format     Abstract available


  152. ORLHAC F, Boughdad S, Philippe C, Stalla-Bourdillon H, et al
    A post-reconstruction harmonization method for multicenter radiomic studies in PET.
    J Nucl Med. 2018 Jan 4. pii: jnumed.117.199935. doi: 10.2967/jnumed.117.199935.
    PubMed     Text format     Abstract available


  153. CHO SY
    Proposed Criteria Positions PSMA PET for the Future.
    J Nucl Med. 2018 Jan 4. pii: jnumed.117.204057. doi: 10.2967/jnumed.117.204057.
    PubMed     Text format    


  154. CALAIS J, Cao M, Nickols NG
    The Utility of PET/CT in External Radiation Therapy Planning of Prostate Cancer.
    J Nucl Med. 2018 Jan 4. pii: jnumed.117.196444. doi: 10.2967/jnumed.117.196444.
    PubMed     Text format     Abstract available


    December 2017
  155. DEVOUS MD SR, Joshi AD, Navitsky M, Southekal S, et al
    Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
    J Nucl Med. 2017 Dec 28. pii: jnumed.117.200691. doi: 10.2967/jnumed.117.200691.
    PubMed     Text format     Abstract available


  156. TURPIN S, Martineau PJ, Levasseur MA, Lambert R, et al
    Modeling the effects of age and gender on normal pediatric brain metabolism using F18-FDG PET/CT.
    J Nucl Med. 2017 Dec 28. pii: jnumed.117.201889. doi: 10.2967/jnumed.117.201889.
    PubMed     Text format     Abstract available


  157. GAREEN IF, Hillner BE, Hanna L, Makineni R, et al
    Hospice Admission and Survival following (18)F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
    J Nucl Med. 2017 Dec 28. pii: jnumed.117.205120. doi: 10.2967/jnumed.117.205120.
    PubMed     Text format     Abstract available


  158. FRANGOS S, Hustinx R, Boubaker A, Varetto T, et al
    The future of the past is the present. The challenge to educate Nuclear Medicine Specialist in present time. The important role of UEMS Section and European Board of Nuclear Medicine.
    J Nucl Med. 2017 Dec 21. pii: jnumed.117.206052. doi: 10.2967/jnumed.117.206052.
    PubMed     Text format    


  159. GIESEL F, Will L, Lawal I, Lengana T, et al
    Intra-individual comparison of (18)F-PSMA-1007 and (18)F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: A pilot study.
    J Nucl Med. 2017 Dec 21. pii: jnumed.117.204669. doi: 10.2967/jnumed.117.204669.
    PubMed     Text format     Abstract available


  160. STABIN M
    New Generation Fetal Dose Estimates for Radiopharmaceuticals.
    J Nucl Med. 2017 Dec 21. pii: jnumed.117.204214. doi: 10.2967/jnumed.117.204214.
    PubMed     Text format     Abstract available


  161. CALAIS J, Fendler WP, Herrmann K, Eiber M, et al
    Head-to-head comparison of (68)Ga-PSMA-11 PET/CT and (18)F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203257. doi: 10.2967/jnumed.117.203257.
    PubMed     Text format     Abstract available


  162. ENILORAC B, Lasnon C, Nganoa C, Fruchart C, et al
    Does PET reconstruction method affect Deauville scoring in lymphoma patients?
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.202721. doi: 10.2967/jnumed.117.202721.
    PubMed     Text format     Abstract available


  163. CECI F, Fendler W, Eiber M
    A new type of prostate cancer imaging. Will (64)CuCl2 PET/CT flourish or vanish?
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.199885. doi: 10.2967/jnumed.117.199885.
    PubMed     Text format    


  164. HAMMES J, Tager P, Drzezga A
    EBONI: A tool for automated quantification of bone metastasis load in PSMA PET/CT.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203265. doi: 10.2967/jnumed.117.203265.
    PubMed     Text format     Abstract available


  165. JADVAR H, Ballas LK
    PSMA PET: Transformational Change in Prostate Cancer Management?
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203604. doi: 10.2967/jnumed.117.203604.
    PubMed     Text format    


  166. WERNER R, Wakabayashi H, Chen X, Hirano M, et al
    Novel functional renal imaging with (18)F-FDS PET in rat models of kidney diseases.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203828. doi: 10.2967/jnumed.117.203828.
    PubMed     Text format     Abstract available


  167. CALAIS J, Fendler WP, Eiber M, Gartmann J, et al
    Actual impact of (68)Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.202945. doi: 10.2967/jnumed.117.202945.
    PubMed     Text format     Abstract available


  168. MURTHY VL, Bateman TM, Beanlands RS, Berman DS, et al
    Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.201368. doi: 10.2967/jnumed.117.201368.
    PubMed     Text format    


  169. CHOI H, Lee DS
    Generation of structural MR images from amyloid PET: Application to MR-less quantification.
    J Nucl Med. 2017 Dec 7. pii: jnumed.117.199414. doi: 10.2967/jnumed.117.199414.
    PubMed     Text format     Abstract available


  170. TAMAKI N
    2017 SNMMI Highlights Lecture: Cardiovascular Nuclear Medicine.
    J Nucl Med. 2017;58:9N-14N.
    PubMed     Text format    


  171. DELEYE S, Waldron AM, Verhaeghe J, Bottelbergs A, et al
    Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease.
    J Nucl Med. 2017;58:1977-1983.
    PubMed     Text format     Abstract available


    November 2017
  172. KRAMER SD, Betzel T, Mu L, Haider A, et al
    Evaluation of [(11)C]Me-NB1 as a potential PET radioligand for measuring GluN2B-containing NMDA receptors, drug occupancy and receptor crosstalk.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.200451. doi: 10.2967/jnumed.117.200451.
    PubMed     Text format     Abstract available


  173. BARANSKI AC, Schafer M, Bauder-Wust U, Roscher M, et al
    PSMA-11 Derived Dual-labeled PSMA-Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.201293. doi: 10.2967/jnumed.117.201293.
    PubMed     Text format     Abstract available


  174. NICOLAS GP, Schreiter N, Kaul F, Uiters J, et al
    Comparison of (68)Ga-OPS202 ((68)Ga-NODAGA-JR11) and (68)Ga-DOTATOC ((68)Ga-Edotreotide) PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Evaluation of Sensitivity in a Prospective Phase II Imaging Study.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.199760. doi: 10.2967/jnumed.117.199760.
    PubMed     Text format     Abstract available


  175. HILLNER BE, Hanna L, Makineni R, Duan F, et al
    Intended vs. Inferred Treatment after (18)F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.205047. doi: 10.2967/jnumed.117.205047.
    PubMed     Text format     Abstract available


  176. VERHEIJEN RB, Yaqub MM, Sawicki E, van Tellingen O, et al
    Molecular Imaging of ABCB1/ABCG2 Inhibition at the Human Blood Brain Barrier using Elacridar and (11)C-Erlotinib PET.
    J Nucl Med. 2017 Nov 24. pii: jnumed.117.195800. doi: 10.2967/jnumed.117.195800.
    PubMed     Text format     Abstract available


  177. BULLICH S, Barthel H, Koglin N, Becker GA, et al
    Validation of Non-Invasive Tracer Kinetic Analysis of (18)F-Florbetaben PET Using a Dual Time-Window Acquisition Protocol.
    J Nucl Med. 2017 Nov 24. pii: jnumed.117.200964. doi: 10.2967/jnumed.117.200964.
    PubMed     Text format     Abstract available


  178. PAPP L, Poetsch N, Grahovac M, Schmidbauer V, et al
    Glioma survival prediction with the combined analysis of in vivo 11C-MET-PET, ex vivo and patient features by supervised machine learning.
    J Nucl Med. 2017 Nov 24. pii: jnumed.117.202267. doi: 10.2967/jnumed.117.202267.
    PubMed     Text format     Abstract available


  179. CHEN J, Wang N, Yang X None, Li Y, et al
    Optimizing Strategies for Immune Checkpoint Imaging with Immumo-PET in Preclinical Study.
    J Nucl Med. 2017 Nov 16. pii: jnumed.117.204685. doi: 10.2967/jnumed.117.204685.
    PubMed     Text format    


  180. ULANER GA, Lyashchenko SK, Riedl C, Ruan S, et al
    First-in-human HER2-targeted imaging using 89Zr-pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer.
    J Nucl Med. 2017 Nov 16. pii: jnumed.117.202010. doi: 10.2967/jnumed.117.202010.
    PubMed     Text format     Abstract available


  181. BARRIO JR
    The Irony of PET Tau Probe Specificity.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198960. doi: 10.2967/jnumed.117.198960.
    PubMed     Text format    


  182. ZHANG J, Niu G, Fan X, Lang L, et al
    Positron Emission Tomography Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198929. doi: 10.2967/jnumed.117.198929.
    PubMed     Text format     Abstract available


  183. CALAIS J, Czernin J, Cao M, Kishan AU, et al
    68Ga-PSMA PET/CT mapping of prostate cancer biochemical recurrence following radical prostatectomy in 270 patients with PSA<1.0ng/ml: Impact on Salvage Radiotherapy Planning.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.201749. doi: 10.2967/jnumed.117.201749.
    PubMed     Text format     Abstract available


  184. EIBER M, Herrmann K, Calais J, Hadaschihk B, et al
    PROstate cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198119. doi: 10.2967/jnumed.117.198119.
    PubMed     Text format     Abstract available


  185. OLIN A, Ladefoged CN, Langer NH, Keller SH, et al
    Reproducibility of MR-based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198853. doi: 10.2967/jnumed.117.198853.
    PubMed     Text format     Abstract available


  186. YOUNG J, Johnson GB, Murphy RC, Go RS, et al
    F-18 FDG PET-CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.200741. doi: 10.2967/jnumed.117.200741.
    PubMed     Text format     Abstract available


  187. TRAN-GIA J, Lassmann M
    Optimizing Image Quantification for Lu-177 SPECT/CT Based on a 3D Printed 2-Compartment Kidney Phantom.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.200170. doi: 10.2967/jnumed.117.200170.
    PubMed     Text format     Abstract available


  188. CIPRIANO P, Yoon D, Gandhi H, Holley D, et al
    18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Non-spinal Abnormalities.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.198259. doi: 10.2967/jnumed.117.198259.
    PubMed     Text format     Abstract available


  189. NAKAMOTO R, Nakamoto Y, Ishimori T, Fushimi Y, et al
    Comparison of PET/CT with sequential PET/MRI using an MR-compatible mobile PET system.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.197665. doi: 10.2967/jnumed.117.197665.
    PubMed     Text format     Abstract available


  190. COLLETTI PM
    2017 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2017;58:11N-15N.
    PubMed     Text format    


  191. BARTHEL H, Sabri O
    Clinical Use and Utility of Amyloid Imaging.
    J Nucl Med. 2017;58:1711-1717.
    PubMed     Text format     Abstract available


  192. BODEI L, Ambrosini V, Herrmann K, Modlin I, et al
    Current Concepts in (68)Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies.
    J Nucl Med. 2017;58:1718-1726.
    PubMed     Text format     Abstract available


  193. GARRIGUE P, Bodin-Hullin A, Balasse L, Fernandez S, et al
    The Evolving Role of Succinate in Tumor Metabolism: An (18)F-FDG-Based Study.
    J Nucl Med. 2017;58:1749-1755.
    PubMed     Text format     Abstract available


  194. ZANOTTI-FREGONARA P, Stabin MG
    New Fetal Radiation Doses for (18)F-FDG Based on Human Data.
    J Nucl Med. 2017;58:1865-1866.
    PubMed     Text format     Abstract available


  195. GHOSH SC, Rodriguez M, Carmon KS, Voss J, et al
    A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.
    J Nucl Med. 2017;58:1858-1864.
    PubMed     Text format     Abstract available


    October 2017
  196. MINAMIMOTO R, Sonni I, Hancock S, Vasanawala S, et al
    Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Conventional Imaging.
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.197624. doi: 10.2967/jnumed.117.197624.
    PubMed     Text format     Abstract available


  197. STEPHENS AW
    Reply: 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi.
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.203687. doi: 10.2967/jnumed.117.203687.
    PubMed     Text format    


  198. LAM WW
    Letter to the Editor: RE: "Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?"
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.203240. doi: 10.2967/jnumed.117.203240.
    PubMed     Text format    


  199. LEYNES AP, Yang J, Wiesinger F, Kaushik SS, et al
    Direct PseudoCT Generation for Pelvis PET/MRI Attenuation Correction using Deep Convolutional Neural Networks with Multi-parametric MRI: Zero Echo-time and Dixon Deep pseudoCT (ZeDD-CT).
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.198051. doi: 10.2967/jnumed.117.198051.
    PubMed     Text format     Abstract available


  200. BIRNIE D, Ohira H, Beanlands R
    Reply: Utilizing and Interpreting FDG-PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil is in the Details.
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.198226. doi: 10.2967/jnumed.117.198226.
    PubMed     Text format    


  201. MUYLLE K, Maffioli L
    Editorial, Nuclear Medicine Training in Europe: "All for one, one for all".
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.201012. doi: 10.2967/jnumed.117.201012.
    PubMed     Text format    


  202. EBENHAN T, Sathekge M, Lenagana T, Koole M, et al
    68Ga-NOTA-functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry and First-in-Human Positron Emission Tomography/Computed Tomography Imaging of Infections.
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.200048. doi: 10.2967/jnumed.117.200048.
    PubMed     Text format     Abstract available


  203. DONNELLY DJ, Smith RA, Morin P, Lipovsek D, et al
    Synthesis and Biological Evaluation of a Novel 18F-labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.199596. doi: 10.2967/jnumed.117.199596.
    PubMed     Text format     Abstract available


  204. WERNER RA, Schmid JS, Higuchi T, Javadi MS, et al
    Predictive value of FDG-PET in patients with advanced medullary thyroid carcinoma treated with vandetanib.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.199778. doi: 10.2967/jnumed.117.199778.
    PubMed     Text format     Abstract available


  205. HOPE TA, Bergsland E, Bozkurt MF, Graham MM, et al
    Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.202275. doi: 10.2967/jnumed.117.202275.
    PubMed     Text format     Abstract available


  206. MARCUS CS
    How Should FDA Review Diagnostic Radiopharmaceuticals?
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.200337. doi: 10.2967/jnumed.117.200337.
    PubMed     Text format     Abstract available


  207. JADVAR H, Colletti P, Delgado-Bolton R, Esposito G, et al
    Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.197988. doi: 10.2967/jnumed.117.197988.
    PubMed     Text format    


  208. SEGALL GM, Grady EE, Fair JR, Ghesani MV, et al
    Editorial, Nuclear Medicine Training in the United States.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.200857. doi: 10.2967/jnumed.117.200857.
    PubMed     Text format    


  209. HOFMAN MS, Eu P, Jackson P, Hong E, et al
    Cold Kit PSMA PET Imaging: Phase I study of 68Ga-THP-PSMA PET/CT in patients with prostate cancer.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.199554. doi: 10.2967/jnumed.117.199554.
    PubMed     Text format     Abstract available


  210. LOPEZ-PICON FR, Snellman A, Eskola O, Helin S, et al
    Neuroinflammation appears early and then plateaus in a mouse model of Alzheimer's disease shown by PET imaging.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.197608. doi: 10.2967/jnumed.117.197608.
    PubMed     Text format     Abstract available


  211. ELSCHOT M, Selnaes KM, Sandsmark E, Kruger-Stokke B, et al
    Combined 18F-Fluciclovine PET/MRI shows potential for detection and characterization of high-risk prostate cancer.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.198598. doi: 10.2967/jnumed.117.198598.
    PubMed     Text format     Abstract available


  212. CZERNIN J
    Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?
    J Nucl Med. 2017;58:1535.
    PubMed     Text format    


  213. GRKOVSKI M, Emmas SA, Carlin SD
    18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.
    J Nucl Med. 2017;58:1567-1573.
    PubMed     Text format     Abstract available


    September 2017
  214. HONER M, Gobbi L, Knust H, Kuwabara H, et al
    Preclinical Evaluation of 18F-RO6958948, 11C-RO6931643 and 11C-RO6924963 as Novel Radiotracers for Imaging Aggregated Tau in AD with Positron Emission Tomography.
    J Nucl Med. 2017 Sep 28. pii: jnumed.117.196741. doi: 10.2967/jnumed.117.196741.
    PubMed     Text format     Abstract available


  215. FARAG S, de Geus-Oei LF, Van der Graaf WT, van Coevorden F, et al
    Early response evaluation by 18F-FDG-PET influences management in gastrointestinal stromal tumor (GIST) patients treated with imatinib with neo-adjuvant intent.
    J Nucl Med. 2017 Sep 28. pii: jnumed.117.196642. doi: 10.2967/jnumed.117.196642.
    PubMed     Text format     Abstract available


  216. ANANTH M, DeLorenzo C, Yang J, Mann JJ, et al
    Decreased pretreatment amygdalae serotonin transporter binding in unipolar depression remitters: a prospective PET study.
    J Nucl Med. 2017 Sep 21. pii: jnumed.117.189654. doi: 10.2967/jnumed.117.189654.
    PubMed     Text format     Abstract available


  217. CHERRY SR, Jones T, Karp JS, Qi J, et al
    TOTAL-BODY PET: MAXIMIZING SENSITIVITY TO CREATE NEW OPPORTUNITIES FOR CLINICAL RESEARCH AND PATIENT CARE.
    J Nucl Med. 2017 Sep 21. pii: jnumed.116.184028. doi: 10.2967/jnumed.116.184028.
    PubMed     Text format     Abstract available


  218. ALVI R, Miller EJ, Hashemi Zonouz T, Sandoval V, et al
    Quantification and Determination of Normal 123I-Meta Iodobenzylguanidine Heart-to-Mediastinum Ratio (HMR) from Cardiac SPECT/CT and Correlation with Planar HMR.
    J Nucl Med. 2017 Sep 15. pii: jnumed.117.197152. doi: 10.2967/jnumed.117.197152.
    PubMed     Text format     Abstract available


  219. REUBI JC
    In Vitro Evaluation Of Molecular Tumor Targets In Nuclear Medicine: Immunohistochemistry Is One Option, But Under Which Conditions?
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.197582. doi: 10.2967/jnumed.117.197582.
    PubMed     Text format     Abstract available


  220. MEYER PT, Frings L, Rucker G, Hellwig S, et al
    18F-FDG PET in Parkinsonism: Differential Diagnosis and Cognitive Impairment in Parkinson's disease.
    J Nucl Med. 2017 Sep 14. pii: jnumed.116.186403. doi: 10.2967/jnumed.116.186403.
    PubMed     Text format     Abstract available


  221. ALAVI A, Werner TJ, Hess S, Hoilund-Carlsen PF, et al
    Letter: RE: 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.200378. doi: 10.2967/jnumed.117.200378.
    PubMed     Text format    


  222. LAW JM, Morris DE, Engbeaya CI, Salem V, et al
    Thermal imaging is a non-invasive alternative to PET-CT for measurement of brown adipose tissue activity in humans.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.190546. doi: 10.2967/jnumed.117.190546.
    PubMed     Text format     Abstract available


  223. STORTZ G, Thiessen JD, Bishop D, Khan MS, et al
    Performance of a PET Insert for High Resolution Small Animal PET/MR Imaging at 7T.
    J Nucl Med. 2017 Sep 14. pii: jnumed.116.187666. doi: 10.2967/jnumed.116.187666.
    PubMed     Text format     Abstract available


  224. LOCKAU HH, Neuschmelting V, Ogirala A, Vilaseca A, et al
    Dynamic 18F-FDG PET- Lymphography for in Vivo Identification of Lymph Node Metastases in Murine Melanoma.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.196303. doi: 10.2967/jnumed.117.196303.
    PubMed     Text format     Abstract available


  225. VENEMA CM, Mammatas LH, Schroder CP, van Kruchten M, et al
    Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.193649. doi: 10.2967/jnumed.117.193649.
    PubMed     Text format     Abstract available


  226. ROWE S, Pienta K, Pomper MG, Gorin M, et al
    Proposal of a Structured Reporting System for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging: PSMA-RADS Version 1.0.
    J Nucl Med. 2017 Sep 8. pii: jnumed.117.195255. doi: 10.2967/jnumed.117.195255.
    PubMed     Text format     Abstract available


  227. STABIN M, Siegel JA
    RADAR DOSE ESTIMATE REPORT: A COMPENDIUM OF RADIOPHARMACEUTICAL DOSE ESTIMATES BASED ON OLINDA/EXM VERSION 2.0.
    J Nucl Med. 2017 Sep 8. pii: jnumed.117.196261. doi: 10.2967/jnumed.117.196261.
    PubMed     Text format     Abstract available


  228. PICCARDO A, Paparo F, Puntoni M, Righi S, et al
    64CuCl2 PET/CT in prostate cancer relapse.
    J Nucl Med. 2017 Sep 8. pii: jnumed.117.195628. doi: 10.2967/jnumed.117.195628.
    PubMed     Text format     Abstract available


  229. HARADA R, Ishiki A, Kai H, Sato N, et al
    Correlations of 18F-THK5351 PET with post-mortem burden of tau and astrogliosis in Alzheimer's disease.
    J Nucl Med. 2017 Sep 1. pii: jnumed.117.197426. doi: 10.2967/jnumed.117.197426.
    PubMed     Text format     Abstract available


  230. ROHDE M, Nielsen AL, Pareek M, Johansen J, et al
    A PET/CT-based strategy is a stronger predictor of survival than a standard imaging strategy in patients with head and neck squamous cell carcinoma.
    J Nucl Med. 2017 Sep 1. pii: jnumed.117.197350. doi: 10.2967/jnumed.117.197350.
    PubMed     Text format     Abstract available


  231. COTTEREAU AS, El-Galaly TC, Becker S, Broussais F, et al
    Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients.
    J Nucl Med. 2017 Sep 1. pii: jnumed.117.193946. doi: 10.2967/jnumed.117.193946.
    PubMed     Text format     Abstract available


  232. HAROLDS JA, Segall GM
    Nuclear Medicine Career Portal for Young Physicians.
    J Nucl Med. 2017;58:12N.
    PubMed     Text format    


  233. EBERLEIN U, Cremonesi M, Lassmann M
    Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
    J Nucl Med. 2017;58.
    PubMed     Text format     Abstract available


  234. HSIAO IT, Lin KJ, Huang KL, Huang CC, et al
    Biodistribution and Radiation Dosimetry for the Tau Tracer 18F-THK-5351 in Healthy Human Subjects.
    J Nucl Med. 2017;58:1498-1503.
    PubMed     Text format     Abstract available


  235. DATTA G, Colasanti A, Kalk N, Owen D, et al
    11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.
    J Nucl Med. 2017;58:1477-1482.
    PubMed     Text format     Abstract available


  236. ZHU Y, Feng J, Ji J, Hou H, et al
    Alteration of Monoamine Receptor Activity and Glucose Metabolism in Pediatric Patients with Anticonvulsant-Induced Cognitive Impairment.
    J Nucl Med. 2017;58:1490-1497.
    PubMed     Text format     Abstract available


  237. SAKATA M, Ishibashi K, Imai M, Wagatsuma K, et al
    Initial Evaluation of an Adenosine A2A Receptor Ligand, 11C-Preladenant, in Healthy Human Subjects.
    J Nucl Med. 2017;58:1464-1470.
    PubMed     Text format     Abstract available


    August 2017
  238. HENRY KE, Dilling TR, Abdel-Atti D, Edwards KJ, et al
    Non-invasive 89Zr-Transferrin PET Shows Improved Tumor Targeting Compared to 18F-FDG PET in MYC-overexpressing Human Triple Negative Breast Cancer.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.192286. doi: 10.2967/jnumed.117.192286.
    PubMed     Text format     Abstract available


  239. HAGE C, Gremse F, Griessinger CM, Maurer A, et al
    Comparison of the Accuracy of FMT/CT and PET/MRI for the Assessment of Antibody Biodistribution in Squamous Cell Carcinoma Xenografts.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.197178. doi: 10.2967/jnumed.117.197178.
    PubMed     Text format     Abstract available


  240. LI J, Zheng H, Fodah RA, Warawa J, et al
    Validation of 2-18F-fluorodeoxysorbitol (18F-FDS) as a potential radiopharmaceutical for imaging bacterial infection in the lung.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.195420. doi: 10.2967/jnumed.117.195420.
    PubMed     Text format     Abstract available


  241. MAULER J, Maudsley AA, Langen KJ, Nikoubashman O, et al
    Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.196709. doi: 10.2967/jnumed.117.196709.
    PubMed     Text format     Abstract available


  242. MANKOFF DA, Pryma DA
    Nuclear Medicine Training: What Now?
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.190132. doi: 10.2967/jnumed.117.190132.
    PubMed     Text format     Abstract available


  243. CORNELIS FH, Durack J, Pandit-Taskar N, Ulaner GA, et al
    Long Half-life 89Zr Labeled Radiotracers Can Guide In Suite Percutaneous Molecular Imaging PET/CT-guided Biopsies Without Reinjection of Radiotracer.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.194480. doi: 10.2967/jnumed.117.194480.
    PubMed     Text format     Abstract available


  244. VELDHUIJZEN VAN ZANTEN SEM, Sewing ACP, van Lingen A, Hoekstra OS, et al
    Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.197897. doi: 10.2967/jnumed.117.197897.
    PubMed     Text format     Abstract available


  245. ARRIETA O, Garcia-Perez FO, Michel-Tello D, Ramirez-Tirado LA, et al
    Response assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT for lung adenocarcinoma patients treated with nintedanib plus docetaxel.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.192393. doi: 10.2967/jnumed.117.192393.
    PubMed     Text format     Abstract available


  246. BARRINGTON SF, Johnson PW
    FDG PET-CT in lymphoma: Has imaging-directed personalized medicine become a reality?
    J Nucl Med. 2017 Aug 10. pii: jnumed.116.181347. doi: 10.2967/jnumed.116.181347.
    PubMed     Text format     Abstract available


  247. LOFGREN J, Mortensen J, Rasmussen SH, Madsen C, et al
    A prospective study comparing 99mTc-HDP planar bone scintigraphy and whole-body SPECT/CT with 18F-fluoride PET/CT and 18F-fluoride PET/MRI for diagnosing bone metastases.
    J Nucl Med. 2017 Aug 10. pii: jnumed.116.189183. doi: 10.2967/jnumed.116.189183.
    PubMed     Text format     Abstract available


  248. PAQUETTE M, Lavallee E, Phoenix S, Ouellet R, et al
    Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 4FMFES in ER+ Breast Cancer Patients: an Ongoing Phase II Clinical Trial.
    J Nucl Med. 2017 Aug 10. pii: jnumed.117.194654. doi: 10.2967/jnumed.117.194654.
    PubMed     Text format     Abstract available


  249. WEIBERG D, Thackeray JT, Daum G, Sohns JM, et al
    Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque using 68Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.196485. doi: 10.2967/jnumed.117.196485.
    PubMed     Text format     Abstract available


  250. WOYTHAL N, Arsenic R, Kempkensteffen C, Miller K, et al
    Immunohistochemical validation of PSMA-expression measured by 68Ga-PSMA PET/CT in primary prostate cancer.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.195172. doi: 10.2967/jnumed.117.195172.
    PubMed     Text format     Abstract available


  251. WANG H, Hou B, Lu L, Feng M, et al
    PET/MR imaging in the diagnosis of hormone-producing pituitary micro-adenoma: a prospective pilot study.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.191916. doi: 10.2967/jnumed.117.191916.
    PubMed     Text format     Abstract available


  252. CHEN X
    Reply: Dual Integrin alphavbeta3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer (68Ga-BBN-RGD).
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.198374. doi: 10.2967/jnumed.117.198374.
    PubMed     Text format    


  253. LE ROUX PY, Salaun PY
    Letter to the Editor: AUC for V/Q Imaging in Pulmonary Embolism. The Elephant in the Room: Planar or SPECT V/Q?
    J Nucl Med. 2017;58:17N.
    PubMed     Text format    


  254. CHAREONTHAITAWEE P, Beanlands RS, Chen W, Dorbala S, et al
    Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.
    J Nucl Med. 2017;58:1341-1353.
    PubMed     Text format    


  255. RICHARD MA, Fouquet JP, Lebel R, Lepage M, et al
    Determination of an Optimal Pharmacokinetic Model of 18F-FET for Quantitative Applications in Rat Brain Tumors.
    J Nucl Med. 2017;58:1278-1284.
    PubMed     Text format     Abstract available


  256. BERGSTROM M
    The Use of Microdosing in the Development of Small Organic and Protein Therapeutics.
    J Nucl Med. 2017;58:1188-1195.
    PubMed     Text format     Abstract available


  257. JO J, Kwon HW, Park S, Oh DY, et al
    Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer.
    J Nucl Med. 2017;58:1255-1261.
    PubMed     Text format     Abstract available


  258. VAN DER AART J, van der Doef TF, Horstman P, Huisman MC, et al
    Human Dosimetry of the N-Methyl-d-Aspartate Receptor Ligand 11C-GMOM.
    J Nucl Med. 2017;58:1330-1333.
    PubMed     Text format     Abstract available


    July 2017
  259. EMMETT L EMMETTHRUB, Van Leeuwen P, Nandurkar R, Scheltema MJ, et al
    Treatment outcomes from 68GaPSMA PET CT informed salvage radiation treatment in men with rising PSA following radical prostatectomy: Prognostic value of a negative PSMA PET.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.196683. doi: 10.2967/jnumed.117.196683.
    PubMed     Text format     Abstract available


  260. NASRALLAH IM, Chen YJ, Hsieh MK, Philips JS, et al
    18F-Flortaucipir PET-MRI correlations in non-amnestic and amnestic variants of Alzheimer Disease.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.194282. doi: 10.2967/jnumed.117.194282.
    PubMed     Text format     Abstract available


  261. DELLER TW, Khalighi MM, Jansen FP, Glover GH, et al
    PET imaging stability measurements during simultaneous pulsing of aggressive MR sequences on the GE SIGNA PET/MR.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.194928. doi: 10.2967/jnumed.117.194928.
    PubMed     Text format     Abstract available


  262. LI S, Cai Z, Zheng MQ, Holden D, et al
    A novel 18F-labeled kappa opioid receptor antagonist as PET radiotracer: Synthesis and in vivo evaluation of 18F-LY2459989 in non-human primates.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.195586. doi: 10.2967/jnumed.117.195586.
    PubMed     Text format     Abstract available


  263. AFAQ A, Alahmed S, Chen SH, Lengana T, et al
    68Ga-PSMA PET/CT impact on prostate cancer management.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.192625. doi: 10.2967/jnumed.117.192625.
    PubMed     Text format     Abstract available


  264. BOUTER C, Meller B, Sahlmann CO, Staab W, et al
    Imaging chemokine receptor CXCR4 in chronic infection of the bone with 68Ga-Pentixafor-PET/CT - first insights.
    J Nucl Med. 2017 Jul 20. pii: jnumed.117.193854. doi: 10.2967/jnumed.117.193854.
    PubMed     Text format     Abstract available


  265. ACKER G, Lange C, Schatka I, Pfeifer A, et al
    Brain perfusion imaging under acetazolamide challenge for detection of impaired cerebrovascular reserve capacity: positive findings with O-15-water PET in patients with negative Tc-99m-HMPAO SPECT.
    J Nucl Med. 2017 Jul 20. pii: jnumed.117.195818. doi: 10.2967/jnumed.117.195818.
    PubMed     Text format     Abstract available


  266. LAMICHHANE N, Dewkar GK, Gobalakrishnan S, Wang L, et al
    Fluorine-18 Labeled Carboplatin Derivative for PET Imaging of Platinum Drug Distribution.
    J Nucl Med. 2017 Jul 20. pii: jnumed.117.191965. doi: 10.2967/jnumed.117.191965.
    PubMed     Text format     Abstract available


  267. BRENDEL M, Focke C, Blume T, Peters F, et al
    Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life-Span of Wild-Type Mice: A PET Study.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.195107. doi: 10.2967/jnumed.117.195107.
    PubMed     Text format     Abstract available


  268. ANTUNES IF, Willemsen ATM, Sijbesma JWA, Boerema AS, et al
    In vivo quantification of ER-beta expression by pharmacokinetic modeling: Studies with 18F-FHNP PET.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.192666. doi: 10.2967/jnumed.117.192666.
    PubMed     Text format     Abstract available


  269. CHEAL SM, Fung EK, Patel MV, Punzalan B, et al
    Curative multi-cycle radioimmunotherapy monitored by quantitative SPECT/CT-based theranostics, using bispecific antibody pretargeting strategy in colorectal cancer.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.193250. doi: 10.2967/jnumed.117.193250.
    PubMed     Text format     Abstract available


  270. PANDIT-TASKAR N, Zanzonico PB, Staton KD, Carrasquillo JA, et al
    Biodistribution and dosimetry of 18F-Meta Fluorobenzyl Guanidine (MFBG): A first-in-human PET-CT imaging study of patients with neuroendocrine malignancies.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.193169. doi: 10.2967/jnumed.117.193169.
    PubMed     Text format     Abstract available


  271. JAMES ML, Hoehne A, Mayer AT, Lechtenberg K, et al
    Imaging B cells in a mouse model of multiple sclerosis using 64Cu-Rituximab-PET.
    J Nucl Med. 2017 Jul 7. pii: jnumed.117.189597. doi: 10.2967/jnumed.117.189597.
    PubMed     Text format     Abstract available


  272. FAHEY FH, Goodkind A, MacDougall RD, Oberg L, et al
    Operational and Dosimetric Aspects of Pediatric PET/CT.
    J Nucl Med. 2017 Jul 7. pii: jnumed.116.182899. doi: 10.2967/jnumed.116.182899.
    PubMed     Text format     Abstract available


  273. SCHWARZENBOCK SM, Rauscher I, Bluemel C, Fendler WP, et al
    PSMA Ligands for PET-Imaging of Prostate Cancer.
    J Nucl Med. 2017 Jul 7. pii: jnumed.117.191031. doi: 10.2967/jnumed.117.191031.
    PubMed     Text format     Abstract available


  274. VAN SCHAIK JPJ, Bennink RJ
    Integrated Residency in Radiology and Nuclear Medicine in The Netherlands.
    J Nucl Med. 2017;58:9N-11N.
    PubMed     Text format    


  275. CARNEY B, Kossatz S, Reiner T
    Molecular Imaging of PARP.
    J Nucl Med. 2017;58:1025-1030.
    PubMed     Text format     Abstract available


  276. HANKIR MK, Kranz M, Keipert S, Weiner J, et al
    Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1-Deficient Mice.
    J Nucl Med. 2017;58:1100-1103.
    PubMed     Text format     Abstract available


  277. JOLING M, Vriend C, van den Heuvel OA, Raijmakers PGHM, et al
    Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.
    J Nucl Med. 2017;58:1117-1123.
    PubMed     Text format     Abstract available


    June 2017
  278. LU Y, Patel DC, Sweiss N
    Utilizing and Interpreting FDG-PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil is in the Details.
    J Nucl Med. 2017 Jun 29. pii: jnumed.117.197004. doi: 10.2967/jnumed.117.197004.
    PubMed     Text format    


  279. BLAIRE T, Bailliez A, Ben Bouallegue F, Bellevre D, et al
    Determination of the heart-to-mediastinum ratio of 123I-MIBG uptake using dual-isotope (123I-MIBG/99mTc-tetrofosmin) multi-pinhole CZT SPECT in patients with heart failure.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.194373. doi: 10.2967/jnumed.117.194373.
    PubMed     Text format     Abstract available


  280. ROACH PJ, Francis R, Emmett L, Hsiao E, et al
    The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.197160. doi: 10.2967/jnumed.117.197160.
    PubMed     Text format     Abstract available


  281. BAUCKNEHT M, Ferrarazzo G, Fiz F, Morbelli S, et al
    Doxorubicin effect on myocardial metabolism as a pre-requisite for subsequent development of cardiac toxicity: a translational 18F-FDG PET/CT observation.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.191122. doi: 10.2967/jnumed.117.191122.
    PubMed     Text format     Abstract available


  282. MAGOTA K, Shiga T, Asano Y, Shinyama D, et al
    Scatter correction with combined single-scatter simulation and Monte Carlo simulation scaling improved the visual artifacts and quantification in 3D brain PET/CT imaging with 15O-gas inhalation.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.193060. doi: 10.2967/jnumed.117.193060.
    PubMed     Text format     Abstract available


  283. HOFMAN MS
    Accuracy in the eye of the beholder: can we improve agreement in prostate cancer diagnostics with PSMA PET/CT?
    J Nucl Med. 2017 Jun 21. pii: jnumed.117.192542. doi: 10.2967/jnumed.117.192542.
    PubMed     Text format    


  284. VINSENSIA M, Choyke PL, Hadaschik B, Holland-Letz T, et al
    68Ga-PSMA PET/CT and volumetric morphology of PET-positive lymph nodes stratified by tumor differentiation of prostate cancer.
    J Nucl Med. 2017 Jun 21. pii: jnumed.116.185033. doi: 10.2967/jnumed.116.185033.
    PubMed     Text format     Abstract available


  285. KOERBER SA, Utzinger MT, Kratochwil C, Kesch C, et al
    68Ga-PSMA11-PET/CT in newly diagnosed carcinoma of the prostate: correlation of intraprostatic PSMA uptake with several clinical parameters.
    J Nucl Med. 2017 Jun 15. pii: jnumed.117.190314. doi: 10.2967/jnumed.117.190314.
    PubMed     Text format     Abstract available


  286. KRAMER GM, Hoekstra OS, Boellaard R
    Reply: Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures in NSCLC Patients: Dynamic versus Test-Retest Design.
    J Nucl Med. 2017 Jun 15. pii: jnumed.117.195461. doi: 10.2967/jnumed.117.195461.
    PubMed     Text format    


  287. WELLS RG, Marvin B, Poirier M, Renaud JM, et al
    Optimization of SPECT Measurement of Myocardial Blood Flow with Corrections for Attenuation, Motion, and Blood-Binding Compared to PET.
    J Nucl Med. 2017 Jun 13. pii: jnumed.117.191049. doi: 10.2967/jnumed.117.191049.
    PubMed     Text format     Abstract available


  288. DESOGERE P, Tapias LF, Rietz TA, Rotile N, et al
    Optimization of a collagen-targeted positron emission tomography probe for molecular imaging of pulmonary fibrosis.
    J Nucl Med. 2017 Jun 13. pii: jnumed.117.193532. doi: 10.2967/jnumed.117.193532.
    PubMed     Text format     Abstract available


  289. WOLFS E, Holvoet B, Ordovas L, Breuls N, et al
    Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nucleases-mediated genome editing.
    J Nucl Med. 2017 Jun 8. pii: jnumed.117.189779. doi: 10.2967/jnumed.117.189779.
    PubMed     Text format     Abstract available


  290. DERCLE L, Seban RD, Lazarovici J, Schwartz L, et al
    18F-FDG PET and CT-scan Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-PD1 Immune Checkpoint Inhibitor.
    J Nucl Med. 2017 Jun 8. pii: jnumed.117.193011. doi: 10.2967/jnumed.117.193011.
    PubMed     Text format     Abstract available


  291. FERREIRA DA PONTE K, Berro DH, Collet S, Constans JM, et al
    In vivo relationship between hypoxia and angiogenesis in human glioblastoma: a multimodal imaging study.
    J Nucl Med. 2017 Jun 8. pii: jnumed.116.188557. doi: 10.2967/jnumed.116.188557.
    PubMed     Text format     Abstract available


  292. GONZALEZ TROTTER DE, Meng X, McQuade P, Rubins D, et al
    In vivo Imaging of the Programmed Death Ligand 1 by 18F Positron Emission Tomography.
    J Nucl Med. 2017 Jun 6. pii: jnumed.117.191718. doi: 10.2967/jnumed.117.191718.
    PubMed     Text format     Abstract available


  293. NA KJ, Choi H
    Tumor metabolic features identified by FDG PET correlates with gene networks of immune cell microenvironment in head and neck cancer.
    J Nucl Med. 2017 Jun 6. pii: jnumed.117.194217. doi: 10.2967/jnumed.117.194217.
    PubMed     Text format     Abstract available


  294. ROHDE M, Nielsen AL, Johansen J, Sorensen JA, et al
    Head-to-head comparison of chest x-ray/head and neck MRI, chest CT/head and neck MRI, and 18F-FDG-PET/CT for detection of distant metastases and synchronous cancer in oral, pharyngeal, and laryngeal Cancer.
    J Nucl Med. 2017 Jun 1. pii: jnumed.117.189704. doi: 10.2967/jnumed.117.189704.
    PubMed     Text format     Abstract available


  295. OSMAN MM, Iravani A, Hofman MS, Hicks RJ, et al
    Detection of Synchronous Primary Malignancies with 68Ga-PSMA PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients.
    J Nucl Med. 2017 Jun 1. pii: jnumed.117.190215. doi: 10.2967/jnumed.117.190215.
    PubMed     Text format     Abstract available


  296. SCHWARZ SW
    SNMMI Leadership Update: An Exciting Time for Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2017;58:19N.
    PubMed     Text format    


  297. WRIGHT CL, Niederkohr RD, Knopp MU, Knopp MV, et al
    Online Social Media Practices in Nuclear Medicine and Molecular Imaging: A Concept to Incentivize Creation of Digital and Web-Based Content.
    J Nucl Med. 2017;58:12N-14N.
    PubMed     Text format    


  298. FENG L, Jensen P, Thomsen G, Dyssegaard A, et al
    The Variability of Translocator Protein Signal in Brain and Blood of Genotyped Healthy Humans Using In Vivo 123I-CLINDE SPECT Imaging: A Test-Retest Study.
    J Nucl Med. 2017;58:989-995.
    PubMed     Text format     Abstract available


  299. KRAMER GM, Frings V, Heijtel D, Smit EF, et al
    Parametric Method Performance for Dynamic 3'-Deoxy-3'-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Carcinoma Patients Before and During Therapy.
    J Nucl Med. 2017;58:920-925.
    PubMed     Text format     Abstract available


  300. PARK S, Ha S, Kwon HW, Kim WH, et al
    Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication.
    J Nucl Med. 2017;58:899-904.
    PubMed     Text format     Abstract available


  301. NEVES AA, Xie B, Fawcett S, Alam IS, et al
    Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I.
    J Nucl Med. 2017;58:881-887.
    PubMed     Text format     Abstract available


  302. VAN ELSSEN CHMJ, Rashidian M, Vrbanac V, Wucherpfennig KW, et al
    Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.
    J Nucl Med. 2017;58:1003-1008.
    PubMed     Text format     Abstract available


  303. GROOTENDORST MR, Cariati M, Pinder SE, Kothari A, et al
    Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study.
    J Nucl Med. 2017;58:891-898.
    PubMed     Text format     Abstract available


  304. BETTHAUSER TJ, Lao PJ, Murali D, Barnhart TE, et al
    In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317.
    J Nucl Med. 2017;58:996-1002.
    PubMed     Text format     Abstract available


    May 2017
  305. JACOBSON O, Chen H, Niu G, Kiesewetter DO, et al
    PET-guided evaluation and optimization of internalized antibody-drug conjugates targeting erythropoietin producing hepatoma A2 receptor.
    J Nucl Med. 2017 May 25. pii: jnumed.117.192245. doi: 10.2967/jnumed.117.192245.
    PubMed     Text format     Abstract available


  306. KOUIJZER I, Kampschreur L, Wever P, Hoekstra C, et al
    The value of 18F-FDG-PET/CT in diagnosis and during follow-up in 273 patients with chronic Q fever.
    J Nucl Med. 2017 May 25. pii: jnumed.117.192492. doi: 10.2967/jnumed.117.192492.
    PubMed     Text format     Abstract available


  307. LE D
    Radiopharmaceuticals for Therapy.
    J Nucl Med. 2017 May 25. pii: jnumed.117.196568. doi: 10.2967/jnumed.117.196568.
    PubMed     Text format    


  308. DORIS MK, Rubeaux M, Pawade T, Otaki Y, et al
    Motion-corrected imaging of the aortic valve with 18F-NaF PET/CT and PET/MR: a feasibility study.
    J Nucl Med. 2017 May 25. pii: jnumed.117.194597. doi: 10.2967/jnumed.117.194597.
    PubMed     Text format     Abstract available


  309. COLLARINO A, Garganese G, Valdes Olmos RA, Stefanelli A, et al
    Evaluation of Dual Time Point Imaging 18F-FDG PET/CT for Lymph Node Staging in Vulvar Cancer.
    J Nucl Med. 2017 May 25. pii: jnumed.117.194332. doi: 10.2967/jnumed.117.194332.
    PubMed     Text format     Abstract available


  310. BIETH M, Kronke M, Tauber R, Dahlbender M, et al
    Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumour Burden in Prostate Cancer using 68Ga-PSMA-PET/CT.
    J Nucl Med. 2017 May 25. pii: jnumed.116.189050. doi: 10.2967/jnumed.116.189050.
    PubMed     Text format     Abstract available


  311. FENDLER WP, Stuparu AD, Evans-Axelsson S, Luckerath K, et al
    Establishing 177Lu-PSMA-617 radioligand therapy in a syngeneic model of murine prostate cancer.
    J Nucl Med. 2017 May 25. pii: jnumed.117.193359. doi: 10.2967/jnumed.117.193359.
    PubMed     Text format     Abstract available


  312. XI M, Liao Z, Hofstetter WL, Komaki R, et al
    FDG-PET Response After Induction Chemotherapy Can Predict Who Will Benefit From Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.
    J Nucl Med. 2017 May 18. pii: jnumed.117.192591. doi: 10.2967/jnumed.117.192591.
    PubMed     Text format     Abstract available


  313. LAMMERTSMA AA
    Forward to the Past: the Case for Quantitative PET Imaging.
    J Nucl Med. 2017 May 18. pii: jnumed.116.188029. doi: 10.2967/jnumed.116.188029.
    PubMed     Text format     Abstract available


  314. KENNEDY-DIXON TG, Gossell-Williams M, Cooper M, Trabelsi M, et al
    Evaluation of radiopharmaceutical adverse reaction reports to the British Nuclear Medicine Society for the period 2007 to 2016.
    J Nucl Med. 2017 May 18. pii: jnumed.117.194092. doi: 10.2967/jnumed.117.194092.
    PubMed     Text format     Abstract available


  315. HOPE TA, Aggarwal R, Chee B, Tao D, et al
    Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2017 May 18. pii: jnumed.117.192476. doi: 10.2967/jnumed.117.192476.
    PubMed     Text format     Abstract available


  316. SCHMUCK S, von Klot CA, Henkenberens C, Sohns JM, et al
    Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer.
    J Nucl Med. 2017 May 18. pii: jnumed.117.193581. doi: 10.2967/jnumed.117.193581.
    PubMed     Text format     Abstract available


  317. FOSS CA, Liu L, Mease RC, Wang H, et al
    Imaging Macrophage Accumulation in a Murine Model of Chronic Pancreatitis with [125I]iodoDPA SPECT-CT.
    J Nucl Med. 2017 May 18. pii: jnumed.117.189571. doi: 10.2967/jnumed.117.189571.
    PubMed     Text format     Abstract available


  318. NEDROW JR, Josefsson A, Park S, Ranka S, et al
    Imaging of programmed death ligand-1 (PD-L1): impact of protein concentration on distribution of anti-PD-L1 SPECT agent in an immunocompetent melanoma murine model.
    J Nucl Med. 2017 May 18. pii: jnumed.117.193268. doi: 10.2967/jnumed.117.193268.
    PubMed     Text format     Abstract available


  319. GOWRISHANKAR G, Hardy J, Wardak M, Namavari M, et al
    Specific Imaging of Bacterial Infection using 6'' -18F-Fluoromaltotriose: A Second Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria.
    J Nucl Med. 2017 May 10. pii: jnumed.117.191452. doi: 10.2967/jnumed.117.191452.
    PubMed     Text format     Abstract available


  320. FLEDELIUS J, Winther-Larsen A, Khalil AA, Bylov CM, et al
    18F-FDG-PET/CT for very early response evaluation predicts CT response in Erlotinib treated NSCLC patients - A comparison of assessment methods.
    J Nucl Med. 2017 May 10. pii: jnumed.117.193003. doi: 10.2967/jnumed.117.193003.
    PubMed     Text format     Abstract available


  321. STEIGER S, Arvanitakis M, Sick B, Weder W, et al
    Analysis of prognostic values of various PET metrics in preoperative FDG PET for early stage bronchial carcinoma for progression free and overall survival: significantly increased glycolysis is a predictive factor.
    J Nucl Med. 2017 May 10. pii: jnumed.117.189894. doi: 10.2967/jnumed.117.189894.
    PubMed     Text format     Abstract available


  322. VAN DER VOS CS, Arens AI, Hamill J J, Hofmann C, et al
    Metal artifact reduction of CT scans to improve PET/CT.
    J Nucl Med. 2017 May 10. pii: jnumed.117.191171. doi: 10.2967/jnumed.117.191171.
    PubMed     Text format     Abstract available


  323. ALEXANDER PK, Lie Y, Jones G, Sivaratnam C, et al
    Management Impact of Imaging Brain Vesicular Monoamine Transporter type-2 (VMAT2) in Clinically Uncertain Parkinsonian Syndrome (CUPS) with 18F-AV133 and PET.
    J Nucl Med. 2017 May 10. pii: jnumed.116.189019. doi: 10.2967/jnumed.116.189019.
    PubMed     Text format     Abstract available


  324. SIEGEL JA, Sacks B, Pennington CW, Welsh JS, et al
    Dose Optimization to Minimize Radiation Risk for Children Undergoing CT and Nuclear Medicine Imaging is Misguided and Detrimental.
    J Nucl Med. 2017 May 10. pii: jnumed.117.195263. doi: 10.2967/jnumed.117.195263.
    PubMed     Text format     Abstract available


  325. SUBRAMANIAM RM, Jadvar H, Colletti PM, Guimaraes A, et al
    American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Body.
    J Nucl Med. 2017 May 4. pii: jnumed.117.193524. doi: 10.2967/jnumed.117.193524.
    PubMed     Text format     Abstract available


  326. CALAIS J, Czernin J, Eiber M, Fendler WP, et al
    Most intended management changes after 68Ga-DOTATATE PET/CT are implemented.
    J Nucl Med. 2017 May 4. pii: jnumed.117.192450. doi: 10.2967/jnumed.117.192450.
    PubMed     Text format     Abstract available


  327. HOFHEINZ F, Apostolova I, Oehme L, Kotzerke J, et al
    Test-retest variability of lesion SUV and lesion SUR in 18F-FDG PET: an analysis of data from two prospective multicenter trials.
    J Nucl Med. 2017 May 4. pii: jnumed.117.190736. doi: 10.2967/jnumed.117.190736.
    PubMed     Text format     Abstract available


  328. BOOIJ J, Dubroff J, Pryma D, Yu JQ, et al
    Diagnostic performance of the visual reading of 123I-ioflupane SPECT images when assessed with or without quantification in patients with movement disorders or dementia.
    J Nucl Med. 2017 May 4. pii: jnumed.116.189266. doi: 10.2967/jnumed.116.189266.
    PubMed     Text format     Abstract available


  329. KAGNA O, Kurash M, Ghanem-Zouabi N, Keidar Z, et al
    Does antibiotic treatment affect the diagnostic accuracy of FDG PET/CT studies in patients with suspected infectious processes?
    J Nucl Med. 2017 May 4. pii: jnumed.117.192062. doi: 10.2967/jnumed.117.192062.
    PubMed     Text format     Abstract available


  330. KESCH C, Vinsensia M, Radtke JP, Schlemmer HP, et al
    Intra-individual comparison of 18F-PSMA-1007-PET/CT, multi-parametric MRI and radical prostatectomy specimen in patients with primary prostate cancer - a retrospective, proof of concept study.
    J Nucl Med. 2017 May 4. pii: jnumed.116.189233. doi: 10.2967/jnumed.116.189233.
    PubMed     Text format     Abstract available


  331. YANG J, Wiesinger F, Kaushik S, Shanbhag D, et al
    Evaluation of sinus/edge corrected ZTE-based attenuation correction in brain PET/MRI.
    J Nucl Med. 2017 May 4. pii: jnumed.116.188268. doi: 10.2967/jnumed.116.188268.
    PubMed     Text format     Abstract available


  332. CLARK PM, Ebiana VA, Gosa L, Cloughesy TF, et al
    Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine.
    J Nucl Med. 2017;58:689-696.
    PubMed     Text format     Abstract available


  333. GARG PK, Nazih R, Wu Y, Singh R, et al
    4-11C-Methoxy N-(2-Diethylaminoethyl) Benzamide: A Novel Probe to Selectively Target Melanoma.
    J Nucl Med. 2017;58:827-832.
    PubMed     Text format     Abstract available


  334. WAN MYS, Endozo R, Michopoulou S, Shortman R, et al
    PET/CT Imaging of Unstable Carotid Plaque with 68Ga-Labeled Somatostatin Receptor Ligand.
    J Nucl Med. 2017;58:774-780.
    PubMed     Text format     Abstract available


  335. MUZIK O, Mangner TJ, Leonard WR, Kumar A, et al
    Sympathetic Innervation of Cold-Activated Brown and White Fat in Lean Young Adults.
    J Nucl Med. 2017;58:799-806.
    PubMed     Text format     Abstract available


  336. SEGTNAN EA, Grupe P, Jarden JO, Gerke O, et al
    Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis.
    J Nucl Med. 2017;58:768-773.
    PubMed     Text format     Abstract available


  337. ILAN E, Sandstrom M, Velikyan I, Sundin A, et al
    Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast.
    J Nucl Med. 2017;58:744-749.
    PubMed     Text format     Abstract available


    April 2017
  338. WONDERGEM M, van der Zant F, Knol R, Lazarenko S, et al
    18F-DCFPyL PET/CT in the detection of prostate cancer at 60 and 120 minutes ; detection rate, image quality, activity kinetics and biodistribution.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.192658. doi: 10.2967/jnumed.117.192658.
    PubMed     Text format     Abstract available


  339. WONG SQ, Tothill RW, Dawson SJ, Hicks RJ, et al
    Wet or Dry? Are Liquid Biopsy Techniques Competing or Complementary Technologies to PET for Disease Monitoring in Oncology?
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190116. doi: 10.2967/jnumed.117.190116.
    PubMed     Text format    


  340. MORBELLI S, Alama A, Ferrarazzo G, Coco S, et al
    Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an 18F-FDG PET/CT study.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193201. doi: 10.2967/jnumed.117.193201.
    PubMed     Text format     Abstract available


  341. HSU DF, Ilan E, Peterson WT, Uribe J, et al
    Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.189514. doi: 10.2967/jnumed.117.189514.
    PubMed     Text format     Abstract available


  342. AHRENS BJ, Li L, Ciminera AK, Chea J, et al
    Diagnostic PET Imaging of Mammary Microcalcifications using 64Cu-DOTA-alendronate in a Rat Model of Breast Cancer.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190850. doi: 10.2967/jnumed.117.190850.
    PubMed     Text format     Abstract available


  343. ENGBERS EM, Timmer JR, Mouden M, Knollema S, et al
    Prognostic value of myocardial perfusion imaging with CZT SPECT camera in patients suspected for coronary artery disease.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188516. doi: 10.2967/jnumed.116.188516.
    PubMed     Text format     Abstract available


  344. KOGA K, Nagai Y, Hanyu M, Yoshinaga M, et al
    High-contrast PET imaging of vasopressin V1B receptors with a novel radioligand, 11C-TASP699.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188698. doi: 10.2967/jnumed.116.188698.
    PubMed     Text format     Abstract available


  345. KASTE SC, Metzger M, Shulkin B
    Reply: Prudence required when using 18F-FDG PET as reference standard for lymphoma detection.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190652. doi: 10.2967/jnumed.117.190652.
    PubMed     Text format    


  346. KUNZ WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, et al
    Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET-CT Compared to Contrast-Enhanced MRI.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.191932. doi: 10.2967/jnumed.117.191932.
    PubMed     Text format     Abstract available


  347. DERLIN T, Gueler F, Brasen JH, Schmitz J, et al
    Integrating MRI and chemokine receptor CXCR4-targeted PET for detection of leukocyte infiltration in complicated urinary tract infections after kidney transplantation.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193037. doi: 10.2967/jnumed.117.193037.
    PubMed     Text format     Abstract available


  348. OSBORN EA, Kessinger CW, Tawakol A, Jaffer FA, et al
    Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.182873. doi: 10.2967/jnumed.116.182873.
    PubMed     Text format     Abstract available


  349. KELLY JM, Amor-Coarasa A, Nikolopoulou A, Wustemann T, et al
    Double Targeting Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188722. doi: 10.2967/jnumed.116.188722.
    PubMed     Text format     Abstract available


  350. DALM SU, Haeck J, Doeswijk GN, de Blois E, et al
    SSTR-mediated Breast Cancer Imaging: Is There A Role For Radiolabeled SSTR Antagonists?
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.189035. doi: 10.2967/jnumed.116.189035.
    PubMed     Text format     Abstract available


  351. YOUNG JD, Abbate V, Imberti C, Meszaros LK, et al
    68Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room temperature, one-step kit-based radiolabeling.
    J Nucl Med. 2017 Apr 13. pii: jnumed.117.191882. doi: 10.2967/jnumed.117.191882.
    PubMed     Text format     Abstract available


  352. FENDLER WP, Calais J, Allen-Auerbach M, Bluemel C, et al
    68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study.
    J Nucl Med. 2017 Apr 13. pii: jnumed.117.190827. doi: 10.2967/jnumed.117.190827.
    PubMed     Text format     Abstract available


  353. O' DOHERTY J, Jauregui-Osoro M, Brothwood T, Szyszko T, et al
    18F-tetrafluoroborate (18F-TFB), a PET probe for imaging sodium-iodide symporter expression: Whole-body biodistribution, safety and radiation dosimetry in thyroid cancer patients.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192252. doi: 10.2967/jnumed.117.192252.
    PubMed     Text format     Abstract available


  354. GERSTNER E
    MRI and PET: noninvasive tools to probe diffuse intrinsic pontine glioma biology.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192526. doi: 10.2967/jnumed.117.192526.
    PubMed     Text format    


  355. KOSTAKOGLU L
    Reply: Fact sheet about interim and end-of-treatment 18F-FDG PET/CT in lymphoma.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.190512. doi: 10.2967/jnumed.117.190512.
    PubMed     Text format    


  356. MILLER MP, Kostakoglu L, Pryma D, Yu JQ, et al
    Reader training for the re-staging of biochemically recurrent prostate cancer using fluciclovine (18F) PET/CT.
    J Nucl Med. 2017 Apr 6. pii: jnumed.116.188375. doi: 10.2967/jnumed.116.188375.
    PubMed     Text format     Abstract available


  357. COLLETTI PM
    2016 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2017;58:9N-12N.
    PubMed     Text format    


  358. DONOHOE KJ, Cohen EJ, Giammarile F, Grady E, et al
    Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and Excerpts.
    J Nucl Med. 2017;58:14N-17N.
    PubMed     Text format    



  359. SNMMI Begins Release of AUC for High-Value Nuclear Medicine Procedures.
    J Nucl Med. 2017;58:13N.
    PubMed     Text format    


  360. ADAMS HJ, Kwee TC
    Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma.
    J Nucl Med. 2017;58:684-685.
    PubMed     Text format    


  361. GROHEUX D
    18F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer.
    J Nucl Med. 2017;58:683.
    PubMed     Text format    


  362. ZHU L, Ploessl K, Zhou R, Mankoff D, et al
    Metabolic Imaging of Glutamine in Cancer.
    J Nucl Med. 2017;58:533-537.
    PubMed     Text format     Abstract available


  363. LEE HJ, Barback CV, Hoh CK, Qin Z, et al
    Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes.
    J Nucl Med. 2017;58:547-553.
    PubMed     Text format     Abstract available


  364. MAYER AT, Natarajan A, Gordon SR, Maute RL, et al
    Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging.
    J Nucl Med. 2017;58:538-546.
    PubMed     Text format     Abstract available


  365. CHEN H, Jacobson O, Niu G, Weiss ID, et al
    Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.
    J Nucl Med. 2017;58:590-597.
    PubMed     Text format     Abstract available


  366. HAGGKVIST J, Toth M, Tari L, Varnas K, et al
    Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex.
    J Nucl Med. 2017;58:617-622.
    PubMed     Text format     Abstract available


  367. HAHN A, Schain M, Erlandsson M, Sjolin P, et al
    Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology.
    J Nucl Med. 2017;58:623-631.
    PubMed     Text format     Abstract available


  368. KLEINJAN GH, Hellingman D, van den Berg NS, van Oosterom MN, et al
    Hybrid Surgical Guidance: Does Hardware Integration of gamma- and Fluorescence Imaging Modalities Make Sense?
    J Nucl Med. 2017;58:646-650.
    PubMed     Text format     Abstract available


    March 2017
  369. ZUKOTYNSKI K, Vajapeyam S, Fahey FH, Kocak M, et al
    Correlation of 18F-FDG PET and MR Apparent Diffusion Coefficient (ADC) Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.185389. doi: 10.2967/jnumed.116.185389.
    PubMed     Text format     Abstract available


  370. O JH, Jacene HA, Luber B, Wang H, et al
    Quantitation of cancer treatment response by FDG PET/CT: multi-center assessment of measurement variability.
    J Nucl Med. 2017 Mar 30. pii: jnumed.117.189605. doi: 10.2967/jnumed.117.189605.
    PubMed     Text format     Abstract available


  371. CHO SY, Lipson EJ, Im HJ, Rowe SP, et al
    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early Time-Point FDG-PET/CT Imaging in Patients with Advanced Melanoma.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.188839. doi: 10.2967/jnumed.116.188839.
    PubMed     Text format     Abstract available


  372. WARNDERS FJ, Terwisscha van Scheltinga AG, Knuehl C, van Roy M, et al
    HER3 specific biodistribution and tumor uptake of 89Zr-MSB0010853 visualized by real-time and non-invasive PET imaging.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.181586. doi: 10.2967/jnumed.116.181586.
    PubMed     Text format     Abstract available


  373. SEITH F, Schmidt H, Kunz J, Kuestner T, et al
    Simulation of tracer dose reduction in 18F-FDG-Positron emission tomography / magnetic resonance imaging (PET/MRI): Effects on oncologic reading, image quality and artifacts.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.184440. doi: 10.2967/jnumed.116.184440.
    PubMed     Text format     Abstract available


  374. VERCELLINO L, Ouvrier MJ, Barre E, Cassinat B, et al
    Assessing bone marrow activity in patients with myelofibrosis: results of a pilot study of 18F-FLT PET.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.188508. doi: 10.2967/jnumed.116.188508.
    PubMed     Text format     Abstract available


  375. BERREVOETS MA, Kouijzer IJ, Aarntzen EH, Janssen MJ, et al
    18F-FDG-PET/CT optimizes treatment in Staphylococcus aureus bacteremia and is associated with reduced mortality.
    J Nucl Med. 2017 Mar 23. pii: jnumed.117.191981. doi: 10.2967/jnumed.117.191981.
    PubMed     Text format     Abstract available


  376. SUCKSDORFF M, Rissanen E, Tuisku J, Nuutinen S, et al
    Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.183020. doi: 10.2967/jnumed.116.183020.
    PubMed     Text format     Abstract available


  377. TEUHO J, Saunavaara V, Tolvanen T, Tuokkola T, et al
    Quantitative evaluation of two scatter correction techniques for 18F-FDG brain PET/MR imaging in regard to MR-based attenuation correction.
    J Nucl Med. 2017 Mar 23. pii: jnumed.117.190231. doi: 10.2967/jnumed.117.190231.
    PubMed     Text format     Abstract available


  378. OTTOY J, Verhaeghe J, Niemantsverdriet E, Wyffels L, et al
    Validation of the semi-quantitative static SUVR method for [18F]-AV45 PET by pharmacokinetic modeling with an arterial input function.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.184481. doi: 10.2967/jnumed.116.184481.
    PubMed     Text format     Abstract available


  379. USMANIJ EA, Natroshvili T, Timmer-Bonte JN, Oyen WJ, et al
    The predictive value of early in-treatment FDG-PET/CT response to chemotherapy in combination with bevacizumab in advanced non-squamous non-small cell lung cancer.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.185314. doi: 10.2967/jnumed.116.185314.
    PubMed     Text format     Abstract available


  380. PIERT M, Shao X, Raffel DM, Davenport MS, et al
    Preclinical evaluation of 11C-sarcosine as a substrate of proton-coupled amino acid transporters and first human application in prostate cancer.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.173179. doi: 10.2967/jnumed.116.173179.
    PubMed     Text format     Abstract available


  381. KRISHNAN S, Otaki Y, Doris M, Slipczuk L, et al
    Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
    J Nucl Med. 2017;58:359-364.
    PubMed     Text format     Abstract available


  382. TERRITO PR, Meyer JA, Peters JS, Riley AA, et al
    Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation.
    J Nucl Med. 2017;58:458-465.
    PubMed     Text format     Abstract available


    February 2017
  383. STEGMAYR C, Oliveira D, Niemietz N, Willuweit A, et al
    Influence of bevacizumab on blood-brain barrier permeability and O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.
    J Nucl Med. 2017 Feb 2. pii: jnumed.116.187047. doi: 10.2967/jnumed.116.187047.
    PubMed     Text format     Abstract available


  384. COTTEREAU AS, Hapdey S, Chartier L, Modzelewski R, et al
    Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.
    J Nucl Med. 2017;58:276-281.
    PubMed     Text format     Abstract available


  385. WANG J, Arulanandam R, Wassenaar R, Falls T, et al
    Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.
    J Nucl Med. 2017;58:221-227.
    PubMed     Text format     Abstract available


  386. BAKER SL, Lockhart SN, Price JC, He M, et al
    Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    J Nucl Med. 2017;58:332-338.
    PubMed     Text format     Abstract available


  387. VAN DER MEER LT, Terry SY, van Ingen Schenau DS, Andree KC, et al
    In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow.
    J Nucl Med. 2017;58:214-220.
    PubMed     Text format     Abstract available


    January 2017
  388. ZHU Y, Wu S, Hou H, Ji J, et al
    Glucose Metabolic Profile by Visual Assessment Combined with SPM Analysis in Pediatric Patients with Epilepsy.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.187492. doi: 10.2967/jnumed.116.187492.
    PubMed     Text format     Abstract available


  389. LAFFON E, Thumerel M, Jougon J, Marthan R, et al
    Cumulated activity Comparison of 64Cu-/177Lu-labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.180521. doi: 10.2967/jnumed.116.180521.
    PubMed     Text format     Abstract available


  390. MOGHBEL MC, Mittra E, Gallamini A, Niederkohr R, et al
    Response Assessment Criteria and Their Applications in Lymphoma: Part 2.
    J Nucl Med. 2017;58:13-22.
    PubMed     Text format     Abstract available


  391. ORDONEZ AA, Weinstein EA, Bambarger LE, Saini V, et al
    A Systematic Approach for Developing Bacteria-Specific Imaging Tracers.
    J Nucl Med. 2017;58:144-150.
    PubMed     Text format     Abstract available


  392. DETOUR J, Pierre A, Boisson F, Kreutter G, et al
    Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
    J Nucl Med. 2017;58:36-41.
    PubMed     Text format     Abstract available


  393. ENGLAND CG, Ehlerding EB, Hernandez R, Rekoske BT, et al
    Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    J Nucl Med. 2017;58:162-168.
    PubMed     Text format     Abstract available


  394. VAN DER GEEST T, Laverman P, Gerrits D, Walgreen B, et al
    Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
    J Nucl Med. 2017;58:151-155.
    PubMed     Text format     Abstract available


  395. SIEGEL JA, Pennington CW, Sacks B
    Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur of Non-Trivial Proportion.
    J Nucl Med. 2017;58:1-6.
    PubMed     Text format     Abstract available


  396. GOLESTANI R, Razavian M, Ye Y, Zhang J, et al
    Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.
    J Nucl Med. 2017;58:138-143.
    PubMed     Text format     Abstract available


  397. LEURQUIN-STERK G, Celen S, Van Laere K, Koole M, et al
    What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
    J Nucl Med. 2017;58:110-116.
    PubMed     Text format     Abstract available


    November 2016
  398. FOWLER AM, Linden HM
    Functional Estrogen Receptor Imaging Prior to Neoadjuvant therapy for Primary Breast Cancer.
    J Nucl Med. 2016 Nov 17. pii: jnumed.116.183533.
    PubMed     Text format    


    October 2016
  399. CARDINALE J, Schafer M, Benesova M, Bauder-Wust U, et al
    Preclinical Evaluation of [18F]PSMA-1007: A New PSMA-Ligand for Prostate Cancer Imaging.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.181768.
    PubMed     Text format     Abstract available


  400. YANG H, Jenni S, Colovic M, Merkens H, et al
    18F-5-fluoro-aminosuberic acid (FASu) as a potential tracer to gauge oxidative stress in breast cancer models.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.180661.
    PubMed     Text format     Abstract available


  401. AFSHAR-OROMIEH A, Babich JW, Kratochwil C, Giesel FL, et al
    The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  402. PANDIT-TASKAR N, Veach DR, Fox JJ, Scher HI, et al
    Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  403. SCHUSTER DM, Nanni C, Fanti S
    Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  404. IAGARU AH, Mittra E, Colletti PM, Jadvar H, et al
    Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  405. JADVAR H
    Radiotheranostics in Prostate Cancer: Introduction and Overview.
    J Nucl Med. 2016;57.
    PubMed     Text format    


    September 2016
  406. YIP SS, Kim J, Coroller T, Parmar C, et al
    Associations between somatic mutations and metabolic imaging phenotypes in non-small cell lung cancer.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.181826.
    PubMed     Text format     Abstract available


  407. OKAMOTO S, Thieme A, Allmann J, D'Alessandria C, et al
    Radiation dosimetry for 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: Absorbed dose in normal organs and tumor lesions.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.178483.
    PubMed     Text format     Abstract available


  408. FINDLAY JM, Bradley KM, Wang LM, Franklin JM, et al
    PREDICTING PATHOLOGICAL RESPONSE OF ESOPHAGEAL CANCER TO NEOADJUVANT CHEMOTHERAPY: THE IMPLICATIONS OF METABOLIC NODAL RESPONSE FOR PERSONALISED THERAPY.
    J Nucl Med. 2016 Sep 15. pii: jnumed.116.176313.
    PubMed     Text format     Abstract available


  409. PALESTRO CJ
    Radionuclide Imaging of Musculoskeletal Infection: A Review.
    J Nucl Med. 2016;57:1406-12.
    PubMed     Text format     Abstract available


  410. HARMS HJ, Huisman MC, Rijnierse MT, Greuter H, et al
    Noninvasive Quantification of Myocardial 11C-Meta-Hydroxyephedrine Kinetics.
    J Nucl Med. 2016;57:1376-81.
    PubMed     Text format     Abstract available


  411. BAILLIEZ A, Lairez O, Merlin C, Piriou N, et al
    Left Ventricular Function Assessment Using 2 Different Cadmium-Zinc-Telluride Cameras Compared with a gamma-Camera with Cardiofocal Collimators: Dynamic Cardiac Phantom Study and Clinical Validation.
    J Nucl Med. 2016;57:1370-5.
    PubMed     Text format     Abstract available


  412. SINGH P, Gonzalez-Ramos S, Mojena M, Rosales-Mendoza CE, et al
    GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.
    J Nucl Med. 2016;57:1428-35.
    PubMed     Text format     Abstract available


    August 2016
  413. ZHANG H, Desai P, Koike Y, Houghton J, et al
    Dual modality imaging of prostate cancer with a fluorescent and radiogallium-labeled GRP receptor antagonist.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.176099.
    PubMed     Text format     Abstract available


  414. DUBASH SR, Keat N, Mapelli P, Twyman F, et al
    Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors.
    J Nucl Med. 2016;57:1207-13.
    PubMed     Text format     Abstract available


  415. SANTINI C, Kuil J, Bunschoten A, Pool S, et al
    Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.
    J Nucl Med. 2016;57:1289-95.
    PubMed     Text format     Abstract available


  416. DOUKKY R, Frogge N, Appis A, Hayes K, et al
    Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging.
    J Nucl Med. 2016;57:1251-7.
    PubMed     Text format     Abstract available


  417. BAUER M, Blaickner M, Philippe C, Wadsak W, et al
    Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans.
    J Nucl Med. 2016;57:1265-8.
    PubMed     Text format     Abstract available


  418. KOBASHI N, Matsumoto H, Zhao S, Meike S, et al
    The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine.
    J Nucl Med. 2016;57:1276-81.
    PubMed     Text format     Abstract available


  419. MEDHORA M, Haworth S, Liu Y, Narayanan J, et al
    Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging.
    J Nucl Med. 2016;57:1296-301.
    PubMed     Text format     Abstract available


    July 2016
  420. SENGUPTA D, Pratx G
    Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy.
    J Nucl Med. 2016;57:1136-40.
    PubMed     Text format     Abstract available


    May 2016
  421. MCCONATHY J
    [F-18]Fluciclovine (FACBC) and its Potential Use for Breast Cancer Imaging.
    J Nucl Med. 2016 May 19. pii: jnumed.116.175489.
    PubMed     Text format    


    April 2016
  422. PARK GM, Kim YH, Yun SC, Ahn JM, et al
    Anatomical or Functional Evaluation as an Initial Test for Stable Coronary Artery Disease: A Propensity Score Analysis.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.169318.
    PubMed     Text format     Abstract available


  423. HUAILEI J, Bansal A, Pandey M, Peng KW, et al
    Synthesis of 18F-Tetrafluoroborate (18F-TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170894.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: